Funders › NY › The Leona M and Harry B Helmsley Charitable Trust › 2023

Grants paid by The Leona M and Harry B Helmsley Charitable Trust, tax year 2023

EIN 13-7184401 · New York, NY · Form 990-PF, Part XV · NTEE T20

In tax year 2023, The Leona M and Harry B Helmsley Charitable Trust (EIN 13-7184401) reported 577 grants paid totaling $433,687,275. Dataset version 2026.09.0, built 2026-09-03.

2021 202220232024 2025

Every grant, 2023 · page 1 of 2

Grants reported by The Leona M and Harry B Helmsley Charitable Trust for tax year 2023
Tax year	Recipient	Match	Amount	Type	Purpose	Source filing
2023	The End Fund Inc New York, NY	B	$22,500,000	paid	NEGLECTED TROPICAL DISEASE: REACHING THE LAST MILE	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$9,542,857	approved, future	CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$9,013,397	approved, future	PEN-PLUS EXPANSION	202400379349100025
2023	Engineering Ministries International USA Colorado Springs, CO	B	$7,020,410	paid	ALASKA WASH PROJECT	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$6,627,661	paid	NEVADA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Geoscience Australia Symonston	U	$6,604,232	paid	DIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT	202400379349100025
2023	Yitzhak Shamir Medical Center Tzrifin	U	$6,082,143	paid	EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$5,785,714	approved, future	CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$5,661,004	paid	PEN-PLUS EXPANSION	202400379349100025
2023	The Baruch Padeh Medical Center Poriya Tiberias	U	$5,431,730	approved, future	THE HELMSLEY REHABILITATION CENTER OF THE NORTH	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$5,226,272	paid	THE HELMSLEY CANCER CENTER AT SHAARE ZEDEK MEDICAL CENTER JERUSALEM	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$5,200,000	approved, future	A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$5,026,234	paid	REDEFINING THE FUTURE OF EMERGENCY MEDICINE	202400379349100025
2023	Fairview Health Services Minneapolis, MN	B	$4,889,200	approved, future	IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$4,885,390	approved, future	MINNESOTA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$4,470,844	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$4,470,844	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	The Baruch Padeh Medical Center Poriya Tiberias	U	$4,453,113	paid	THE HELMSLEY REHABILITATION CENTER OF THE NORTH	202400379349100025
2023	World Health Organization Geneva	U	$4,420,294	paid	STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$4,395,700	approved, future	THE HELMSLEY CENTER FOR INNOVATIVE SURGICAL TRAINING	202400379349100025
2023	Jerusalem College of Technology Jerusalem	U	$4,165,000	paid	HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$4,136,248	approved, future	THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$4,136,248	approved, future	THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$4,100,000	paid	A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER	202400379349100025
2023	Holy Rosary Healthcare Foundation Miles City, MT	B	$4,000,000	paid	HOLY ROSARY HEALTHCARE COMPREHENSIVE CANCER CENTER	202400379349100025
2023	Hadassah Medical Organization Jerusalem	U	$3,864,000	paid	CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$3,847,500	paid	YOSEFTAL HOSPITAL ADDITION	202400379349100025
2023	New York University School of Medicine New York, NY	C	$3,692,303	approved, future	TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH	202400379349100025
2023	Central Montana Medical Facilities Inc Lewistown, MT	B	$3,690,035	approved, future	CANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER	202400379349100025
2023	Bhsh System Grand Rapids, MI	U	$3,670,399	paid	STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$3,614,073	paid	THE HELMSLEY CENTER FOR INNOVATIVE SURGICAL TRAINING	202400379349100025
2023	World Health Organization Geneva	U	$3,521,461	approved, future	STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$3,500,000	paid	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$3,480,533	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$3,480,533	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$3,470,843	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Central Montana Medical Facilities Inc Lewistown, MT	B	$3,469,965	paid	CANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER	202400379349100025
2023	Fairview Health Services Minneapolis, MN	B	$3,176,500	approved, future	IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE	202400379349100025
2023	Hillel Yaffe Medical Center Hadera	U	$3,158,400	approved, future	EYE INSTITUTE AND AMBULATORY SURGERY CENTER	202400379349100025
2023	National Park Foundation Washington, DC	B	$3,150,000	paid	LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER	202400379349100025
2023	Bhsh System Grand Rapids, MI	U	$3,104,271	approved, future	STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS	202400379349100025
2023	Renown Health Foundation Reno, NV	C	$3,099,867	paid	SIMULATION AND INNOVATION CENTER AT RENOWN HEALTH	202400379349100025
2023	The Jewish Agency for Israel Jerusalem	D	$3,000,000	paid	FLIGHTS FOR NEW IMMIGRANTS FROM RUSSIA	202400379349100025
2023	Diabetes Nsw Sydney	U	$3,000,000	paid	IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES	202400379349100025
2023	Diabetes Nsw Sydney	U	$3,000,000	approved, future	IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES	202400379349100025
2023	Diabetes Nsw Sydney	U	$3,000,000	approved, future	IMPROVE OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, VIA GEOGRAPHIC EXPANSION AND COUNTRY-DRIVEN INITIATIVES	202400379349100025
2023	Children's Mercy Hospital Kansas City, MO	B	$2,966,873	paid	TYPE 1 DIABETES RAPID LEARNING LAB	202400379349100025
2023	Sanford Fargo, ND	U	$2,894,734	paid	SANFORD HEALTH ULTRASOUND PROJECT	202400379349100025
2023	Bridges to Prosperity Inc Denver, CO	D	$2,812,542	paid	TRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA	202400379349100025
2023	State of Nv Dept of Conservation and Natural Res Div of State Parks Carson City, NV	U	$2,800,000	approved, future	ICE AGE FOSSIL STATE PARK TRAILS AND OUTDOOR AMENITIES	202400379349100025
2023	New York University School of Medicine New York, NY	C	$2,756,847	approved, future	TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH	202400379349100025
2023	Hillel Yaffe Medical Center Hadera	U	$2,756,300	paid	EYE INSTITUTE AND AMBULATORY SURGERY CENTER	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$2,739,000	paid	PURCHASING THE REQUISITE EQUIPMENT FOR ESTABLISHING THE SHEBA PANDEMIC PREPAREDNESS RESEARCH INSTITUTE (SPRI)	202400379349100025
2023	World Health Organization Geneva	U	$2,738,915	approved, future	STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$2,700,000	paid	UPGRADED PET-CT SCANNER UTILIZING NEW TECHNOLOGICAL DEVELOPMENTS FOR MORE ACCURATE, QUICKER AND SAFER DIAGNOSIS AND MONITORING.	202400379349100025
2023	Bnai Zion Medical Center Haifa	U	$2,665,020	paid	ACQUISITION OF A DA VINCI XI SURGICAL SYSTEM WITH SINGLE CONSOLE + FIREFLY ROBOTIC SURGICAL SYSTEM.	202400379349100025
2023	The Academic College at Tel-Hai Upper Galilee	U	$2,664,333	approved, future	THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH	202400379349100025
2023	Bridges to Prosperity Inc Denver, CO	D	$2,648,126	approved, future	TRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA	202400379349100025
2023	Jdrf Australia Sydney	U	$2,595,980	paid	ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,584,495	approved, future	CONTINUATION OF THE GPPAD-02-STUDY: IDENTIFICATION OF INFANTS WITH INCREASED T1D RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$2,567,417	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$2,567,417	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$2,521,277	approved, future	MISSION: LIFELINE STROKE IOWA	202400379349100025
2023	Civica Foundation Lehi, UT	B	$2,500,000	approved, future	AFFORDABLE INSULIN	202400379349100025
2023	Civica Foundation Lehi, UT	B	$2,500,000	approved, future	AFFORDABLE INSULIN	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$2,500,000	approved, future	QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS	202400379349100025
2023	Anthos Home Inc Brooklyn, NY	C	$2,500,000	paid	LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$2,500,000	paid	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	The Baruch Padeh Medical Center Poriya Tiberias	U	$2,500,000	paid	ROBOTIC ASSISTED SURGERY - PURCHASE OF A SURGICAL ROBOT	202400379349100025
2023	Anthos Home Inc Brooklyn, NY	C	$2,500,000	approved, future	LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS	202400379349100025
2023	Anthos Home Inc Brooklyn, NY	C	$2,500,000	approved, future	LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS	202400379349100025
2023	National Park Foundation Washington, DC	B	$2,449,328	paid	BERING LAND BRIDGE VISITOR CENTER	202400379349100025
2023	Ncd Alliance Geneva	U	$2,409,000	paid	2023-2025 PARTNERSHIP	202400379349100025
2023	Minnesota Academy of Family Physicians Foundation Minneapolis, MN	C	$2,362,600	paid	POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$2,342,997	paid	SUPPORT OF IMAGING AND PATIENT TREATMENT EQUIPMENT FOR THE HELMSLEY CANCER CENTER AND THE HELMSLEY NEUROLOGICAL INSTITUTE	202400379349100025
2023	The Sderot Development Foundation Sderot	U	$2,284,718	approved, future	ESTABLISHING A WARM HOME COMPLEX FOR CHILDREN AT RISK IN SDEROT	202400379349100025
2023	Galilee Medical Center Nahariya	U	$2,200,000	approved, future	RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER	202400379349100025
2023	Galilee Medical Center Nahariya	U	$2,200,000	approved, future	RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,193,719	approved, future	IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,193,718	approved, future	IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS	202400379349100025
2023	Wateraid America Inc New York, NY	B	$2,166,773	paid	RESOLUTION TO REVOLUTION: CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA (R2R)	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$2,105,298	approved, future	MISSION: LIFELINE STROKE IOWA	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,101,247	paid	IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS	202400379349100025
2023	Bhsh System Grand Rapids, MI	U	$2,081,202	approved, future	STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS	202400379349100025
2023	The Academic College at Tel-Hai Upper Galilee	U	$2,078,769	approved, future	THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$2,058,214	paid	YOSEFTAL HOSPITAL ADDITION	202400379349100025
2023	A Glimmer of Hope Foundation Austin, TX	C	$2,053,426	approved, future	EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,040,499	approved, future	THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Minnesota Academy of Family Physicians Foundation Minneapolis, MN	C	$2,016,319	approved, future	POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS	202400379349100025
2023	Path Seattle, WA	C	$2,004,478	paid	THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$2,000,000	paid	QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS	202400379349100025
2023	Holy Rosary Healthcare Foundation Miles City, MT	B	$2,000,000	approved, future	HOLY ROSARY HEALTHCARE COMPREHENSIVE CANCER CENTER	202400379349100025
2023	Kmr Advancement of Medical Centers Ltd Haifa	U	$2,000,000	paid	PROPOSAL FOR BUILDING OF PRINCIPAL INFRASTRUCTURE FOR ALL 20 FLOORS OF THE HELMSLEY HEALTH DISCOVERY TOWER	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$2,000,000	paid	GPPAD BIOSAMPLE RFP	202400379349100025
2023	Pennington County Health and Human Services Rapid City, SD	U	$2,000,000	paid	PENNINGTON COUNTY CRISIS STABILIZATION UNIT	202400379349100025
2023	Schwartzreisman Science Education Center Rehovot (ra) Rehovot	U	$1,982,305	approved, future	THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT	202400379349100025
2023	Yitzhak Shamir Medical Center Tzrifin	U	$1,978,286	approved, future	EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER	202400379349100025
2023	American Pharmacists Association Foundation Washington, DC	B	$1,976,075	paid	PROJECT IMPACT CGM: EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,973,807	paid	THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Fairview Health Services Minneapolis, MN	B	$1,960,000	approved, future	IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,942,299	paid	DEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D	202400379349100025
2023	Incline Village Community Hospital Foundation Incline Village, NV	B	$1,938,683	paid	MAMMOGRAPHY FOR INCLINE VILLAGE COMMUNITY HOSPITAL	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$1,917,417	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	Ncd Alliance Geneva	U	$1,911,525	approved, future	2023-2025 PARTNERSHIP	202400379349100025
2023	National Park Foundation Washington, DC	B	$1,850,000	approved, future	BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER	202400379349100025
2023	Path Seattle, WA	C	$1,838,580	approved, future	THE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE	202400379349100025
2023	Minnesota Academy of Family Physicians Foundation Minneapolis, MN	C	$1,801,545	approved, future	POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$1,795,816	approved, future	AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$1,785,375	approved, future	GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$1,783,316	approved, future	AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT	202400379349100025
2023	United States African Development Foundation Washington, DC	U	$1,779,762	paid	LIVELIHOOD IMPROVEMENT PROGRAM	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$1,750,000	approved, future	THE QUANTUM MATERIALS DEVICES FABRICATION LAB	202400379349100025
2023	Centracare Health System St Cloud, MN	B	$1,746,643	paid	CENTRACARE HEALTH SYSTEM ULTRASOUND PROJECT	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,741,076	paid	EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT)	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$1,740,267	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	Blue Circle Health Inc Wilmington, DE	U	$1,740,266	approved, future	DEVELOPMENT OF BLUE CIRCLE HEALTH	202400379349100025
2023	University of Kansas Center for Research Inc Lawrence, KS	B	$1,740,145	paid	PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D	202400379349100025
2023	Stichting Pharmaccess International Amsterdam	U	$1,712,785	paid	MED4ALL EXPANSION	202400379349100025
2023	The Academic College at Tel-Hai Upper Galilee	U	$1,685,000	paid	THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$1,680,053	paid	MISSION: LIFELINE STROKE IOWA	202400379349100025
2023	Water4 Inc Oklahoma City, OK	C	$1,673,164	approved, future	SCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$1,671,429	paid	CONSTRUCTION OF THE LEONA B. AND HARRY M. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING	202400379349100025
2023	Helen Keller International New York, NY	C	$1,652,490	approved, future	A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT	202400379349100025
2023	Fund for Public Housing Inc New York, NY	B	$1,630,000	approved, future	DEVELOPING AND ACTIVATING GREENSPACE USING THE CONNECTED COMMUNITIES' PARTICIPATORY PROCESS AT FOUR NYCHA DEVELOPMENTS	202400379349100025
2023	Foundation for Innovative New Diagnostics Find Geneva	D	$1,614,046	approved, future	ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT	202400379349100025
2023	Clinton Health Access Initiative Inc Boston, MA	B	$1,597,167	paid	MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE	202400379349100025
2023	The Regents of the University of California at Irvine Irvine, CA	C	$1,597,074	approved, future	DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D	202400379349100025
2023	Safe Water Network New York, NY	B	$1,595,750	paid	SCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY	202400379349100025
2023	Ncd Alliance Geneva	U	$1,582,350	approved, future	2023-2025 PARTNERSHIP	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$1,576,052	paid	GENETICS INSTITUTE AND GENOMICS CENTER	202400379349100025
2023	Fund for Public Housing Inc New York, NY	B	$1,570,000	paid	DEVELOPING AND ACTIVATING GREENSPACE USING THE CONNECTED COMMUNITIES' PARTICIPATORY PROCESS AT FOUR NYCHA DEVELOPMENTS	202400379349100025
2023	Catholic Relief Services-Usccb Baltimore, MD	C	$1,556,214	paid	INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT (ICOWASH 2.0)	202400379349100025
2023	Safe Water Network New York, NY	B	$1,552,050	approved, future	SCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$1,520,614	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	Global Solidarity Fund New York, NY	D	$1,508,200	paid	JOB CREATION IN ETHIOPIA	202400379349100025
2023	Global Solidarity Fund New York, NY	D	$1,508,200	approved, future	JOB CREATION IN ETHIOPIA	202400379349100025
2023	American Pharmacists Association Foundation Washington, DC	B	$1,502,893	approved, future	PROJECT IMPACT CGM: EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES	202400379349100025
2023	Dreamed Diabetes Ltd Petah Tikva	U	$1,500,000	paid	INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES	202400379349100025
2023	Avera Mckennan for the Avera Mckennan Hospital and Uni Health Center Sioux Falls, SD	U	$1,500,000	paid	AVERA BEHAVIORAL HEALTH CENTER EXPANSION	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$1,500,000	paid	NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$1,500,000	paid	NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE	202400379349100025
2023	Avera Mckennan for the Avera Mckennan Hospital and Uni Health Center Sioux Falls, SD	U	$1,500,000	approved, future	AVERA BEHAVIORAL HEALTH CENTER EXPANSION	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$1,500,000	approved, future	NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$1,500,000	approved, future	NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE	202400379349100025
2023	Aquaya Institute San Anselmo, CA	C	$1,492,399	paid	WATER QUALITY ASSURANCE FUND EXPANSION IN GHANA	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,486,275	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,486,274	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,483,787	approved, future	DEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,481,163	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,481,162	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,479,330	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,479,329	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Essentia Health Duluth, MN	B	$1,473,638	paid	ESSENTIA HEALTH ULTRASOUND PROJECT	202400379349100025
2023	New Venture Fund Washington, DC	B	$1,468,813	approved, future	TYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)	202400379349100025
2023	Washoe Barton Medical Clinic Gardnerville, NV	D	$1,465,248	paid	CARSON VALLEY MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT	202400379349100025
2023	Henry J Kaiser Family Foundation San Francisco, CA	B	$1,458,159	approved, future	KAISER HEALTH NEWS RURAL HEALTH DESK	202400379349100025
2023	A Glimmer of Hope Foundation Austin, TX	C	$1,446,574	approved, future	EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$1,445,914	approved, future	CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM	202400379349100025
2023	Helen Keller International New York, NY	C	$1,441,293	approved, future	A CONTINUED PATH TO RESILIENCE AND EMPOWERMENT	202400379349100025
2023	Water4 Inc Oklahoma City, OK	C	$1,439,503	paid	SCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER	202400379349100025
2023	New Venture Fund Washington, DC	B	$1,435,500	paid	TYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,431,241	approved, future	THE GPPAD-02 STUDY: IDENTIFICATION OF INFANTS WITH HIGH RISK OF TYPE 1 DIABETES FOR PRIMARY PREVENTION	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$1,421,241	approved, future	ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$1,420,270	approved, future	GENETICS INSTITUTE AND GENOMICS CENTER	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,415,657	paid	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,412,946	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,412,946	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Children's Mercy Hospital Kansas City, MO	B	$1,399,624	approved, future	TYPE 1 DIABETES RAPID LEARNING LAB	202400379349100025
2023	Sos Children's Villages-USA Inc Washington, DC	C	$1,386,577	paid	EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA	202400379349100025
2023	Alaska Native Tribal Health Consortium Anchorage, AK	B	$1,373,068	paid	YAKUTAT UTILITY PROJECT	202400379349100025
2023	Living Water International Stafford, TX	B	$1,369,113	paid	INTEGRATED WATER ACCESS, SANITATION AND HYGIENE PROGRAM IN CHIPATA DISTRICT, ZAMBIA	202400379349100025
2023	New York University School of Medicine New York, NY	C	$1,360,453	approved, future	TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$1,355,310	approved, future	DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,352,233	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,352,232	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Dreamed Diabetes Ltd Petah Tikva	U	$1,350,000	approved, future	INCREASING ACCESS TO DECISION SUPPORT TOOLS FOR IMPROVED INSULIN DOSING FOR PEOPLE WITH DIABETES	202400379349100025
2023	Catholic Relief Services-Usccb Baltimore, MD	C	$1,344,542	paid	REST4D - RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR SYSTEM DEVELOPMENT	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$1,338,570	paid	ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS: A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL).	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$1,335,936	paid	CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$1,333,324	paid	NEVADA VIRTUAL CRISIS CARE	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$1,329,719	paid	GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS	202400379349100025
2023	King's College London London	U	$1,325,562	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$1,321,419	paid	MISSION: LIFELINE STROKE MONTANA AND POST-ACUTE STROKE CARE QUALITY STANDARDS FIELD TESTING	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$1,321,210	approved, future	DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$1,320,206	paid	DECODING PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IMPACTING CLINICAL AND PROGNOSTIC FEATURES IN CROHNS DISEASE	202400379349100025
2023	The Regents of the University of California San Diego La Jolla, CA	C	$1,309,981	paid	THE DRUGGABLE GPCROME IN CROHNS DISEASE	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$1,308,107	paid	GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS	202400379349100025
2023	Klinikum Der Ludwig-Maximilians-Universitat Munchen Munchen	U	$1,304,315	paid	FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE	202400379349100025
2023	A Glimmer of Hope Foundation Austin, TX	C	$1,300,000	paid	EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY	202400379349100025
2023	Jerusalem College of Technology Jerusalem	U	$1,300,000	approved, future	HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$1,296,918	approved, future	MINNESOTA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,296,812	paid	EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT)	202400379349100025
2023	King's College London London	U	$1,296,483	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Stichting Health Action International Amsterdam	U	$1,287,681	paid	ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE III	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$1,285,307	paid	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$1,285,307	paid	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$1,283,708	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	United States African Development Foundation Washington, DC	U	$1,283,255	approved, future	LIVELIHOOD IMPROVEMENT PROGRAM	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,257,107	paid	THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$1,255,105	approved, future	DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$1,249,403	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES	202400379349100025
2023	Stichting Health Action International Amsterdam	U	$1,245,075	approved, future	ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE III	202400379349100025
2023	Clinton Health Access Initiative Inc Boston, MA	B	$1,243,053	approved, future	MARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$1,239,092	approved, future	NEVADA VIRTUAL CRISIS CARE	202400379349100025
2023	University of Glasgow Court Glasgow	U	$1,231,291	approved, future	COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$1,230,038	approved, future	NEVADA VIRTUAL CRISIS CARE	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$1,226,580	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: BOSTON STUDIES	202400379349100025
2023	Seattle Children's Hospital Seattle, WA	U	$1,224,949	paid	DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D - STAGE 3 STUDIES	202400379349100025
2023	Project Nyame Nsa Ltd Manhasset, NY	U	$1,215,500	paid	FARM EXPANSION FOR SUSTAINABILITY	202400379349100025
2023	Snv Netherlands Development Organisation Den Haag	U	$1,207,754	paid	HEALTHY FUTURE FOR ALL (HF4A) IMPROVING WATER, SANITATION, HYGIENE AND NUTRITION	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$1,200,000	approved, future	CAPACITY BUILDING SUPPORT	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$1,200,000	approved, future	CAPACITY BUILDING SUPPORT	202400379349100025
2023	University of Florida Gainesville, FL	U	$1,199,692	paid	THE NETWORK FOR PANCREATIC ORGAN DONORS WITH DIABETES (NPOD): A COLLABORATIVE TYPE 1 DIABETES RESEARCH PROJECT	202400379349100025
2023	Jdrf Australia Sydney	U	$1,196,912	approved, future	ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$1,189,617	paid	INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE	202400379349100025
2023	The Regents of the University of New Mexico Albuquerque, NM	U	$1,188,238	paid	THE ECHO INSTITUTE: ADDRESSING GLOBAL HEALTHCARE DISPARITIES THROUGH REPLICATION OF THE ECHO MODEL	202400379349100025
2023	Rambam Health Corporation Haifa	D	$1,186,800	approved, future	MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$1,185,400	paid	IBD VENTURES ACADEMIC INCUBATOR	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$1,180,400	approved, future	IBD VENTURES ACADEMIC INCUBATOR	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$1,180,400	approved, future	IBD VENTURES ACADEMIC INCUBATOR	202400379349100025
2023	The Sderot Development Foundation Sderot	U	$1,179,326	paid	SDEROT MEDICAL CENTER	202400379349100025
2023	The University of Manchester Manchester	U	$1,177,927	paid	A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION	202400379349100025
2023	Research Triangle Institute Research Triangle Park, NC	C	$1,172,646	paid	USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$1,169,515	paid	PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)	202400379349100025
2023	Panorama Global Seattle, WA	B	$1,167,087	approved, future	PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND	202400379349100025
2023	National Park Foundation Washington, DC	B	$1,163,270	approved, future	BERING LAND BRIDGE VISITOR CENTER	202400379349100025
2023	King's College London London	U	$1,147,254	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$1,143,133	paid	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$1,129,976	approved, future	UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS	202400379349100025
2023	A Glimmer of Hope Foundation Austin, TX	C	$1,129,775	paid	INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA	202400379349100025
2023	Foundation for Innovative New Diagnostics Find Geneva	D	$1,119,378	paid	ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT	202400379349100025
2023	Sanford Research Sioux Fall, SD	C	$1,118,635	approved, future	PLEDGE PHASE 3	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$1,118,516	approved, future	GENETICS INSTITUTE AND GENOMICS CENTER	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$1,116,830	approved, future	DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR	202400379349100025
2023	The University of Manchester Manchester	U	$1,113,915	approved, future	A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$1,111,050	paid	CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION	202400379349100025
2023	Research Triangle Institute Research Triangle Park, NC	C	$1,110,288	approved, future	USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$1,102,824	approved, future	POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA	202400379349100025
2023	Catholic Relief Services-Usccb Baltimore, MD	C	$1,100,098	paid	MAYI MWANA PROJECT: HELPING ZAMBIAN MOTHERS AND NEWBORNS SURVIVE AND THRIVE	202400379349100025
2023	American College of Diabetology Inc Fayetteville, NC	B	$1,093,900	approved, future	IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$1,093,319	approved, future	ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE	202400379349100025
2023	The Regents of the University of California San Diego La Jolla, CA	C	$1,092,733	approved, future	THE DRUGGABLE GPCROME IN CROHNS DISEASE	202400379349100025
2023	The Regents of the University of California San Diego La Jolla, CA	C	$1,091,471	approved, future	THE DRUGGABLE GPCROME IN CROHNS DISEASE	202400379349100025
2023	American College of Diabetology Inc Fayetteville, NC	B	$1,087,885	approved, future	IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS	202400379349100025
2023	Sanford Research Sioux Fall, SD	C	$1,086,430	approved, future	PLEDGE PHASE 3	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$1,081,500	paid	DEVELOPMENT AND EVALUATION OF A NOVEL ALGORITHM FOR AID CONTROL FOR PREGNANT WOMEN WITH T1D	202400379349100025
2023	The Imperial College of Science Technology and Medicine London	U	$1,081,289	approved, future	UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE	202400379349100025
2023	King's College London London	U	$1,079,926	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Chi Health Foundation Omaha, NE	U	$1,079,546	paid	ULTRASOUND PROJECTS AT BAUDETTE, BRECKENRIDGE, LITTLE FALLS, AND PARK RAPIDS, MINNESOTA	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$1,072,041	approved, future	DEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM FOR THE PREVENTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D	202400379349100025
2023	King's College London London	U	$1,069,889	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$1,067,400	approved, future	TRAINING AWARDS PROGRAM - CLASS OF 2021	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$1,067,400	paid	TRAINING AWARDS PROGRAM - CLASS OF 2021	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$1,066,797	paid	COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE.	202400379349100025
2023	Synergos Institute Inc New York, NY	B	$1,063,518	paid	IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$1,060,000	approved, future	CAPACITY BUILDING SUPPORT	202400379349100025
2023	Henry J Kaiser Family Foundation San Francisco, CA	B	$1,057,620	paid	KAISER HEALTH NEWS RURAL HEALTH DESK	202400379349100025
2023	Golden Rainbow of Nevada Inc Las Vegas, NV	B	$1,050,000	paid	CAPITAL SUPPORT FOR GOLDEN RAINBOW OF NEVADA, INC. HOUSING	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$1,047,134	paid	SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY	202400379349100025
2023	New York University New York, NY	B	$1,046,686	paid	IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S DISEASE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,046,486	approved, future	GPPAD BIOSAMPLE RFP	202400379349100025
2023	University of Florida Gainesville, FL	U	$1,043,638	paid	HUMAN ATLAS OF NEONATAL DEVELOPMENTAL AND EARLY LIFE PANCREAS / IMMUNITY (HANDEL)-P/I CONTINUATION	202400379349100025
2023	Nevada Community Foundation Inc Las Vegas, NV	C	$1,035,951	paid	RURAL NEVADA ULTRASOUND CARE INITIATIVE	202400379349100025
2023	The Imperial College of Science Technology and Medicine London	U	$1,032,574	approved, future	UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$1,032,229	paid	CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$1,027,184	approved, future	DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR	202400379349100025
2023	Social Science Research Council Brooklyn, NY	B	$1,024,408	paid	DATA2GO.NYC REVAMP AND DATA CLINIC	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$1,024,257	approved, future	MISSION: LIFELINE STROKE MONTANA AND POST-ACUTE STROKE CARE QUALITY STANDARDS FIELD TESTING	202400379349100025
2023	The One Love Foundation in Honor of Yeardley Love Inc Bronxville, NY	U	$1,023,100	paid	BUILDING FOR THE FUTURE	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$1,019,519	paid	DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR	202400379349100025
2023	The Regents of the University of California San Diego La Jolla, CA	C	$1,016,890	approved, future	MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN	202400379349100025
2023	The Regents of the University of California San Diego La Jolla, CA	C	$1,015,503	paid	MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN	202400379349100025
2023	Sanford Research Sioux Fall, SD	C	$1,013,239	paid	PLEDGE PHASE 3	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$1,011,199	approved, future	HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$1,009,535	approved, future	DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,009,155	paid	MICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$1,008,526	approved, future	CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$1,005,939	paid	PROFESSIONAL VERSION OF DIABETESWISE: AVENUE TO INCREASE DIABETES DEVICE UPTAKE IN PEOPLE WITH INSULIN-REQUIRING DIABETES	202400379349100025
2023	St Luke Health Care Foundation West Chicago, IL	C	$1,005,020	paid	REPLACEMENT OF ESSENTIAL HEALTH CARE EQUIPMENT	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,004,503	approved, future	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$1,004,503	approved, future	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Center for Health Care Strategies Inc Trenton, NJ	B	$1,002,514	approved, future	TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN	202400379349100025
2023	Eb Research Partnership Inc New York, NY	B	$1,000,000	paid	EB RESEARCH PARTNERSHIP ACCELERATOR	202400379349100025
2023	Pennington County Health and Human Services Rapid City, SD	U	$1,000,000	approved, future	PENNINGTON COUNTY CRISIS STABILIZATION UNIT	202400379349100025
2023	Avera Mckennan for the Avera Mckennan Hospital and Uni Health Center Sioux Falls, SD	U	$1,000,000	approved, future	AVERA BEHAVIORAL HEALTH CENTER EXPANSION	202400379349100025
2023	Tidepool Project Palo Alto, CA	B	$1,000,000	paid	TIDEPOOL DATA PLATFORM EXPANSION	202400379349100025
2023	Billings Clinic Foundation Billings, MT	C	$1,000,000	paid	MONTANA PSYCHIATRY RESIDENCY PROGRAM SUSTAINING SUPPORT	202400379349100025
2023	Pennington County Health and Human Services Rapid City, SD	U	$1,000,000	approved, future	PENNINGTON COUNTY CRISIS STABILIZATION UNIT	202400379349100025
2023	The United Nations Institute for Training and Research Geneva	U	$1,000,000	paid	ACCELERATING ACCESS TO TREATMENT AND CARE FOR PEOPLE LIVING WITH NON-COMMUNICABLE DISEASES IN LOW AND MIDDLE-INCOME COUNTRIES.	202400379349100025
2023	University of Iowa Iowa City, IA	U	$999,877	paid	SIMULATION IN MOTION IOWA (SIM-IA)	202400379349100025
2023	Jdrf International New York, NY	U	$999,800	paid	JDRF GLOBAL DIABETES ACCESS INITIATIVE	202400379349100025
2023	Panorama Global Seattle, WA	B	$999,473	paid	PANORAMA - TYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$998,931	approved, future	ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS: A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL).	202400379349100025
2023	The Aspen Institute Inc Washington, DC	B	$998,081	approved, future	BUILDING VISIONARY AND EFFECTIVE TEAMS TO ACCELERATE PROGRESS AGAINST TYPE 1 DIABETES (T1D) AND OTHER NON-COMMUNICABLE DISEASES (NCDS)	202400379349100025
2023	The Imperial College of Science Technology and Medicine London	U	$997,937	paid	UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE	202400379349100025
2023	Jdrf Australia Sydney	U	$997,843	approved, future	ENDIA FOLLOW UP 2023-2025 + SAMPLES ANALYSIS RFA	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$996,262	approved, future	HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE	202400379349100025
2023	The Aspen Institute Inc Washington, DC	B	$996,251	paid	BUILDING VISIONARY AND EFFECTIVE TEAMS TO ACCELERATE PROGRESS AGAINST TYPE 1 DIABETES (T1D) AND OTHER NON-COMMUNICABLE DISEASES (NCDS)	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$994,996	approved, future	PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$993,762	paid	HEARTCORPS: AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE	202400379349100025
2023	The Sderot Development Foundation Sderot	U	$993,626	approved, future	SDEROT MEDICAL CENTER	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$989,083	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$971,014	approved, future	UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$966,865	paid	MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS	202400379349100025
2023	Snv Netherlands Development Organisation Den Haag	U	$962,857	approved, future	HEALTHY FUTURE FOR ALL (HF4A) IMPROVING WATER, SANITATION, HYGIENE AND NUTRITION	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$961,620	approved, future	DECODING THE CLINICAL IMPACT OF HOST AND MICROBIAL INTESTINAL PROTEOMIC LANDSCAPE IN CROHNS DISEASE	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$956,452	paid	UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS	202400379349100025
2023	Cambridge University Hospitals Nhs Foundation Trust Cambridge	U	$955,956	paid	THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$954,604	paid	CROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS	202400379349100025
2023	Rambam Health Corporation Haifa	D	$951,750	paid	MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$948,928	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	Alimentiv Inc London	U	$948,511	paid	STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$941,738	paid	MAYO CLINIC HEALTH SYSTEM POINT-OF-CARE ULTRASOUND EQUIPMENT	202400379349100025
2023	Joslin Diabetes Center Inc Boston, MA	B	$941,354	approved, future	AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$940,000	approved, future	CAPACITY BUILDING SUPPORT	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$938,641	approved, future	COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE.	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$934,083	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT	202400379349100025
2023	Australasian Gastro Intestinal Research Foundation Ltd Fitzroy	U	$907,233	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES	202400379349100025
2023	Southcentral Foundation Anchorage, AK	B	$903,411	approved, future	FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM	202400379349100025
2023	Public Health Solutions New York, NY	B	$900,000	paid	NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE	202400379349100025
2023	University of Massachusetts Medical School Worcester, MA	U	$881,959	approved, future	DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS	202400379349100025
2023	University of Melbourne Victoria	D	$880,551	approved, future	ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR	202400379349100025
2023	Stichting Access to Medicine Foundation Amsterdam	U	$875,000	approved, future	EXPANDING ACCESS TO T1D CARE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$870,315	approved, future	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$870,314	approved, future	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	United States Fund for Unicef New York, NY	U	$869,232	approved, future	ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS	202400379349100025
2023	New York City Health and Hospitals Corporation New York, NY	C	$867,832	approved, future	EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC	202400379349100025
2023	University Hospitals Health System Inc Cleveland, OH	U	$866,199	approved, future	TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS	202400379349100025
2023	Weill Medical College of Cornell University New York, NY	U	$863,618	approved, future	TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Weill Medical College of Cornell University New York, NY	U	$863,618	paid	TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$859,607	approved, future	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Joslin Diabetes Center Inc Boston, MA	B	$857,270	approved, future	AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES	202400379349100025
2023	Association of Diabetes Care & Education Specialists Chicago, IL	B	$855,546	approved, future	EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$854,515	approved, future	MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC)	202400379349100025
2023	Mainehealth Portland, ME	U	$848,894	approved, future	TRANSFORMING RURAL DIABETES CARE IN MAINE	202400379349100025
2023	University of Notre Dame du Lac Notre Dame, IN	U	$848,637	approved, future	DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM	202400379349100025
2023	Massachusetts General Hospital Boston, MA	C	$843,986	paid	WIRELESS INFRARED IMAGING CAPSULE FOR PINPOINTING INFLAMMATION IN CROHNS DISEASE	202400379349100025
2023	University of Florida Gainesville, FL	U	$837,493	paid	HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$836,979	approved, future	INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE	202400379349100025
2023	National Committee for Quality Assurance Washington, DC	B	$836,732	approved, future	NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$835,489	approved, future	PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE)	202400379349100025
2023	Association of Diabetes Care & Education Specialists Chicago, IL	B	$831,327	approved, future	EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE	202400379349100025
2023	Research Triangle Institute Research Triangle Park, NC	C	$826,376	approved, future	USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS: A STATEWIDE IMPLEMENTATION STUDY	202400379349100025
2023	King's College London London	U	$825,146	approved, future	PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)	202400379349100025
2023	Southcentral Foundation Anchorage, AK	B	$818,043	approved, future	FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$817,475	paid	PROFESSIONAL VERSION OF DIABETESWISE: AVENUE TO INCREASE DIABETES DEVICE UPTAKE IN PEOPLE WITH INSULIN-REQUIRING DIABETES	202400379349100025
2023	King's College London London	U	$816,358	paid	PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)	202400379349100025
2023	Public Health Solutions New York, NY	B	$812,335	paid	NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS	202400379349100025
2023	American College of Diabetology Inc Fayetteville, NC	B	$810,203	paid	IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$807,155	paid	INNODIA EXPANSION	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$805,382	approved, future	TRAINING AND MENTORSHIP PROGRAMS	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$805,382	approved, future	TRAINING AND MENTORSHIP PROGRAMS	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$805,382	approved, future	TRAINING AND MENTORSHIP PROGRAMS	202400379349100025
2023	New York City Health and Hospitals Corporation New York, NY	C	$800,000	paid	EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$798,066	paid	ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)	202400379349100025
2023	Beth Israel Deaconess Medical Center Inc Boston, MA	B	$797,851	approved, future	PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Beth Israel Deaconess Medical Center Inc Boston, MA	B	$797,851	approved, future	PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$784,875	paid	AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT	202400379349100025
2023	The University of Chicago Chicago, IL	U	$784,751	approved, future	DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND	202400379349100025
2023	United States Fund for Unicef New York, NY	U	$784,421	approved, future	ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS	202400379349100025
2023	King's College London London	U	$781,151	approved, future	PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY)	202400379349100025
2023	Oakland University Rochester, MI	B	$780,628	paid	A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 1)	202400379349100025
2023	Foundation for Innovative New Diagnostics Find Geneva	D	$779,789	approved, future	ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$779,716	approved, future	PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS.	202400379349100025
2023	International Bowel Ultrasound Group Ev Munster	U	$779,377	paid	DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE.	202400379349100025
2023	King's College London London	U	$778,535	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$770,816	approved, future	COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY	202400379349100025
2023	Cambridge University Hospitals Nhs Foundation Trust Cambridge	U	$767,757	approved, future	THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE	202400379349100025
2023	Saint Louis University Saint Louis, MO	B	$765,477	paid	IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES	202400379349100025
2023	Ben-Gurion University of the Negev Beer Sheva	D	$765,436	approved, future	COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CROHN'S DISEASE.	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$759,619	approved, future	THE MELODY TRIAL: MODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S DISEASE	202400379349100025
2023	Allina Associated Foundation Minneapolis, MN	U	$758,911	paid	ALLINA HEALTH ULTRASOUND PROJECT	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$756,699	approved, future	ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)	202400379349100025
2023	Innodia Leuven	U	$755,460	paid	INNODIA NONPROFIT LAUNCH FOR THE CARE AND PREVENTION OF T1D.	202400379349100025
2023	National Committee for Quality Assurance Washington, DC	B	$753,478	approved, future	NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT	202400379349100025
2023	Americares Foundation Inc Stamford, CT	C	$752,688	paid	MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS	202400379349100025
2023	Massachusetts General Hospital Boston, MA	C	$752,326	approved, future	WIRELESS INFRARED IMAGING CAPSULE FOR PINPOINTING INFLAMMATION IN CROHNS DISEASE	202400379349100025
2023	Healthpartners Institute Bloomington, MN	C	$751,067	paid	DIRECT INTEGRATION OF CGM DATA INTO THE EMR	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$750,000	paid	ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$750,000	approved, future	ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE	202400379349100025
2023	Stichting Access to Medicine Foundation Amsterdam	U	$750,000	paid	EXPANDING ACCESS TO T1D CARE	202400379349100025
2023	Jdrf International New York, NY	U	$750,000	paid	JDRF TRAINING PROGRAMS	202400379349100025
2023	Americares Foundation Inc Stamford, CT	C	$749,599	approved, future	MATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS	202400379349100025
2023	Catholic Relief Services-Usccb Baltimore, MD	C	$749,145	paid	KOM-YILMA III BURKINA FASO	202400379349100025
2023	University of Iowa Iowa City, IA	U	$748,244	approved, future	SIMULATION IN MOTION IOWA (SIM-IA)	202400379349100025
2023	Rambam Health Corporation Haifa	D	$746,990	approved, future	MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CROHN'S	202400379349100025
2023	Ichud Hatzalah Israel 1221 (ra) Jerusalem	U	$739,000	paid	UNITED HATZALAH HUMANITARIAN MISSION FOR UKRAINE	202400379349100025
2023	Adventist Health Systemsunbelt Inc Orlando, FL	C	$731,837	paid	DETERMINING WHETHER A NOVEL CLASS OF DRUGS MIGHT PREVENT HYPOGLYCEMIA IN T1D PATIENTS	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$725,157	approved, future	DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D	202400379349100025
2023	International Bowel Ultrasound Group Ev Munster	U	$718,578	paid	DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE.	202400379349100025
2023	University of Cambridge Cambridge	U	$718,215	approved, future	EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE	202400379349100025
2023	Alyn Hospital - Rehabilitation Center for Children and Youth Jerusalem	U	$717,219	paid	ALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH	202400379349100025
2023	University of Cambridge Cambridge	U	$713,088	approved, future	EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE	202400379349100025
2023	University of Cambridge Cambridge	U	$711,485	paid	EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE	202400379349100025
2023	University Hospitals Health System Inc Cleveland, OH	U	$707,339	approved, future	TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS	202400379349100025
2023	University of Kansas Center for Research Inc Lawrence, KS	B	$706,324	approved, future	PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D	202400379349100025
2023	Massachusetts General Hospital Boston, MA	C	$705,894	approved, future	CROHN'S DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION AND BETTER TREATMENT	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$705,874	paid	EVALUATING THE FEASIBILITY OF AUTOMATED INSULIN DELIVERY IN PRIMARY CARE AND THROUGH TELEHEALTH	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$704,764	approved, future	ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$701,873	paid	DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$701,215	approved, future	THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$701,115	paid	DECODING THE CLINICAL IMPACT OF HOST AND MICROBIAL INTESTINAL PROTEOMIC LANDSCAPE IN CROHNS DISEASE	202400379349100025
2023	Geisinger Clinic Danville, PA	B	$701,056	paid	STUDY OF PRE-IMPLEMENTATION OUTCOMES REQUIRED TO IMPLEMENT PREVENTIVE SCREENING AT WELL-CHILD VISITS	202400379349100025
2023	Vayu Health Portola Valley, CA	B	$700,486	paid	VAYU FEASIBILITY PILOT	202400379349100025
2023	Fund for Public Health in New York Inc New York, NY	B	$700,467	paid	NYC VACCINE EQUITY PARTNER ENGAGEMENT PROJECT	202400379349100025
2023	Simulation in Motion Montana Inc Helena, MT	B	$700,000	paid	SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$700,000	approved, future	A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$698,657	paid	INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$697,881	paid	IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS	202400379349100025
2023	Trustees of Indiana University Bloomington, MI	U	$696,962	paid	MOLECULAR DESIGN AND TESTING OF GLUCOSE-RESPONSIVE THERAPIES	202400379349100025
2023	Ccm Health Montevideo, MN	U	$696,689	paid	CCM HEALTH ULTRASOUND PROJECT	202400379349100025
2023	Alyn Hospital - Rehabilitation Center for Children and Youth Jerusalem	U	$694,034	approved, future	ALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH	202400379349100025
2023	The University of Manchester Manchester	U	$692,839	approved, future	A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$691,810	paid	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$690,953	paid	INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE	202400379349100025
2023	Children's Hospital Los Angeles Los Angeles, CA	U	$684,686	approved, future	BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE	202400379349100025
2023	Avera Health Sioux Falls, SD	B	$682,498	paid	AVERA HEALTH ULTRASOUND PROJECT	202400379349100025
2023	Hadassah Medical Organization Jerusalem	U	$681,600	approved, future	CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER	202400379349100025
2023	City Parks Foundation New York, NY	B	$680,000	paid	NYC GREEN RELIEF & RECOVERY FUND	202400379349100025
2023	Children's Hospital Los Angeles Los Angeles, CA	U	$679,025	approved, future	BEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE	202400379349100025
2023	University Hospitals Health System Inc Cleveland, OH	U	$677,700	approved, future	TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS	202400379349100025
2023	Medicines for Humanity Inc Rockland, MA	B	$677,164	paid	MAI MBELEKI II EXPANSION	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$672,617	approved, future	PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS.	202400379349100025
2023	University of Glasgow Court Glasgow	U	$672,494	paid	COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY	202400379349100025
2023	Hebrew University of Jerusalem Jerusalem	D	$671,024	paid	METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE	202400379349100025
2023	Care-for-Rare Foundation Munich	U	$667,252	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$666,216	approved, future	NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI)	202400379349100025
2023	University of Florida Gainesville, FL	U	$665,910	approved, future	HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$665,654	approved, future	NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI)	202400379349100025
2023	Benaroya Research Institute at Virginia Mason Seattle, WA	B	$661,927	approved, future	LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D	202400379349100025
2023	The Weizmann Institute of Science Rehovot	D	$660,000	paid	THE QUANTUM MATERIALS DEVICES FABRICATION LAB	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$659,685	approved, future	EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY	202400379349100025
2023	Cambridge University Hospitals Nhs Foundation Trust Cambridge	U	$657,605	approved, future	THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$657,403	approved, future	DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$656,542	paid	COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY	202400379349100025
2023	Washington University Saint Louis, MO	B	$656,480	paid	COVID-19 VACCINE RESPONSES IN PATIENTS WITH AUTOIMMUNE DISEASE (COVARIPAD)	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$656,092	paid	COMBINATORIAL SINGLE CELL STRATEGIES FOR A CROHN'S DISEASE GUT CELL ATLAS	202400379349100025
2023	Care-for-Rare Foundation Munich	U	$655,603	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MUNICH STUDIES	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$654,234	approved, future	NICH BAY AREA EXPANSION	202400379349100025
2023	Center for Health Care Strategies Inc Trenton, NJ	B	$653,574	paid	TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$652,589	approved, future	DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$650,000	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$650,000	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	Klinikum Der Ludwig-Maximilians-Universitat Munchen Munchen	U	$649,424	approved, future	FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE	202400379349100025
2023	The Jewish Agency for Israel Jerusalem	D	$645,910	paid	THE JEWISH AGENCY SECURITY FUND (THE FUND)	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$644,244	paid	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$635,535	paid	MAYO CLINIC HEALTH SYSTEM ULTRASOUND PROJECT	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$633,709	approved, future	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	Center for Health Care Strategies Inc Trenton, NJ	B	$626,707	approved, future	TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN	202400379349100025
2023	Bipartisan Policy Center Inc Washington, DC	B	$625,293	paid	STRENGTHENING HEALTH CARE DELIVERY AND SERVICES IN RURAL AND FRONTIER AMERICA	202400379349100025
2023	Guardian Org Foundation Washington, DC	B	$625,000	approved, future	A GROWING CRISIS: NON-COMMUNICABLE DISEASES, AN INDEPENDENT JOURNALISM SERIES BY THE GUARDIAN	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$625,000	paid	EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY	202400379349100025
2023	Board of Regents Nevada System of Higher Education Reno, NV	B	$624,068	paid	ULTRASOUND TRAINING INITIATIVE IN NEVADA	202400379349100025
2023	National Committee for Quality Assurance Washington, DC	B	$621,487	approved, future	NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$618,790	paid	MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC)	202400379349100025
2023	New York City Health and Hospitals Corporation New York, NY	C	$614,668	approved, future	EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC	202400379349100025
2023	The University of Adelaide Adelaide	U	$612,868	paid	ENDIA SCIENCE CONTINUATION	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$612,073	approved, future	SEEDS PATHWAY: SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY	202400379349100025
2023	Amc Medical Research Bv Amsterdam	U	$610,817	paid	IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE	202400379349100025
2023	Saint Louis University Saint Louis, MO	B	$608,523	approved, future	IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES	202400379349100025
2023	Saint Louis University Saint Louis, MO	B	$608,000	approved, future	IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$607,893	paid	CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR DIABETES CARE FOR LATINO PATIENTS: FEASIBILITY AND DISSEMINATION TO DIABETES CENTERS IN THE US	202400379349100025
2023	Klinikum Der Ludwig-Maximilians-Universitat Munchen Munchen	U	$606,581	approved, future	FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE	202400379349100025
2023	Nevada Health Centers Inc Carson City, NV	B	$602,796	paid	QUALITY ULTRASOUND SERVICES AND TRAINING PROGRAM	202400379349100025
2023	Klinikum Der Ludwig-Maximilians-Universitat Munchen Munchen	U	$600,891	approved, future	FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$599,718	paid	BIOMARKER-BASED MULTIDISCIPLINARY TEAM (BIO-MDT) APPROACH TO PERSONALIZED MICROBIAL-TARGETED TREATMENT OF POUCHITIS AND CROHN'S DISEASE	202400379349100025
2023	Board of Regents Nevada System of Higher Education Reno, NV	B	$597,995	paid	CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM	202400379349100025
2023	Social Science Research Council Brooklyn, NY	B	$597,446	approved, future	DATA2GO.NYC REVAMP AND DATA CLINIC	202400379349100025
2023	Mainehealth Portland, ME	U	$596,795	approved, future	TRANSFORMING RURAL DIABETES CARE IN MAINE	202400379349100025
2023	Minnesota State Colleges and Universities St Paul, MN	U	$595,848	paid	EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA	202400379349100025
2023	The Regents of the University of California at Irvine Irvine, CA	C	$594,335	approved, future	DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D	202400379349100025
2023	Vayu Health Portola Valley, CA	B	$591,068	paid	VAYU FEASIBILITY PILOT	202400379349100025
2023	The Hospital for Sick Children Toronto	U	$589,623	paid	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$588,266	approved, future	SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$588,266	approved, future	SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE	202400379349100025
2023	Australasian Gastro Intestinal Research Foundation Ltd Fitzroy	U	$587,840	paid	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES	202400379349100025
2023	Australasian Gastro Intestinal Research Foundation Ltd Fitzroy	U	$587,840	paid	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES	202400379349100025
2023	Breaking Ground Housing Development Fund Corporation New York, NY	B	$585,924	approved, future	PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$585,750	paid	GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES	202400379349100025
2023	University of Nebraska Foundation Lincoln, NE	C	$582,072	paid	SIMULATION IN MOTION NEBRASKA SUSTAINABILITY AND BUSINESS MODEL DEVELOPMENT	202400379349100025
2023	University of North Carolina at Chapel Hill Chapel Hill, NC	B	$581,625	approved, future	GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$580,677	paid	CGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION	202400379349100025
2023	University of Kansas Center for Research Inc Lawrence, KS	B	$579,370	approved, future	PRECLINICAL DEVELOPMENT TO ADVANCE A TYPE 1 DIABETES ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D	202400379349100025
2023	University at Buffalo Pediatric Associates P C Buffalo, NY	D	$576,839	approved, future	FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$575,810	approved, future	ASK THE EXPERTS	202400379349100025
2023	Lakewood Health System Staples, MN	B	$574,338	paid	LAKEWOOD HEALTH SYSTEM ULTRASOUND PROJECT	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$571,287	approved, future	TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$570,831	paid	SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE	202400379349100025
2023	Crohn's & Colitis Foundation Inc New York, NY	B	$570,830	paid	SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CROHNS DISEASE	202400379349100025
2023	University of Florida Gainesville, FL	U	$569,086	approved, future	HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION	202400379349100025
2023	The Regents of the University of California Los Angeles Los Angeles, CA	U	$568,851	approved, future	GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$568,782	approved, future	TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS	202400379349100025
2023	The Regents of the University of California Los Angeles Los Angeles, CA	U	$568,027	approved, future	GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D	202400379349100025
2023	Benaroya Research Institute at Virginia Mason Seattle, WA	B	$567,763	approved, future	LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D	202400379349100025
2023	Breaking Ground Housing Development Fund Corporation New York, NY	B	$567,155	approved, future	PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING	202400379349100025
2023	University of Exeter Exeter	U	$566,086	approved, future	EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM	202400379349100025
2023	Johns Hopkins University Baltimore, MD	U	$562,008	paid	TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS	202400379349100025
2023	Arad Municipality Arad	U	$560,000	paid	ARAD OCCUPATIONAL REHABILITATION CENTER	202400379349100025
2023	Albert Einstein College of Medicine Bronx, NY	B	$556,499	approved, future	PRECLINICAL ACTIVITIES TO ADVANCE D-PEPTIDES AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$556,046	paid	ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA	202400379349100025
2023	The Hospital for Sick Children Toronto	U	$555,480	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES	202400379349100025
2023	Jdrf International New York, NY	U	$555,046	approved, future	AUTOIMMUNITY SCREENING FOR KIDS PROGRAM TRANSITION TOWARDS A SUSTAINABLE SCREENING FOR T1D AND CELIAC DISEASE IN COLORADO	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$551,070	paid	EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHNS DISEASE	202400379349100025
2023	The Hospital for Sick Children Toronto	U	$548,276	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$547,667	paid	PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE FOR NYCS MOST VULNERABLE MEMBERS, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS.	202400379349100025
2023	Breaking Ground Housing Development Fund Corporation New York, NY	B	$547,655	paid	PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING	202400379349100025
2023	Baylor College of Medicine Houston, TX	B	$547,540	approved, future	PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE	202400379349100025
2023	Massachusetts General Hospital Boston, MA	C	$546,985	paid	TETHERED CAPSULE ENDOMICROSCOPY FOR DETAILED VISUALIZATION OF THE CROHN'S BOWEL WALL	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$546,306	paid	PHARMACOLOGICAL MODULATION TO RESTORE COUNTERREGULATORY GLUCAGON SECRETION IN TYPE 1 DIABETES	202400379349100025
2023	Nebraska Departof Health & Human Services Division of Public Health Lincoln, NE	U	$545,083	paid	NEBRASKA FIRST RESPONDER AED PROJECT	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$543,207	paid	ASK THE EXPERTS	202400379349100025
2023	University of Notre Dame du Lac Notre Dame, IN	U	$542,672	approved, future	GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES	202400379349100025
2023	Alimentiv Inc London	U	$542,299	approved, future	STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM	202400379349100025
2023	Lake Region Healthcare Corporation Fergus Falls, MN	B	$538,148	paid	LAKE REGION HEALTHCARE CORPORATION ULTRASOUND PROJECT	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$537,711	paid	ENGINEERING ISLET ANTIGEN-SPECIFIC TREGS FOR T1D	202400379349100025
2023	Baylor College of Medicine Houston, TX	B	$532,841	approved, future	PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS: SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$530,354	paid	AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$527,468	paid	RCT OF TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHNS DISEASE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$526,471	approved, future	THE GPPAD-04 STUDY: SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A)	202400379349100025
2023	Dartmouth- Hitchcock Clinic Lebanon, NH	B	$525,177	approved, future	CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM	202400379349100025
2023	Baylor College of Medicine Houston, TX	B	$524,854	approved, future	PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$522,999	paid	LONG-TERM RESPONSES TO SARS-COV-2 VACCINATION IN A DIVERSE INFLAMMATORY BOWEL DISEASE POPULATION: A MULTI-OMIC STUDY	202400379349100025
2023	Beth Israel Deaconess Medical Center Inc Boston, MA	B	$519,550	paid	PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE.	202400379349100025
2023	Floresta USA Incorporated San Diego, CA	C	$516,231	paid	SCALING AT THE WATERSHED LEVEL TO EQUIP RURAL FAMILIES	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$513,083	paid	GPPAD COORDINATION CENTER CONTINUATION	202400379349100025
2023	Jdrf International New York, NY	U	$511,143	paid	AUTOIMMUNITY SCREENING FOR KIDS PROGRAM TRANSITION TOWARDS A SUSTAINABLE SCREENING FOR T1D AND CELIAC DISEASE IN COLORADO	202400379349100025
2023	Dartmouth- Hitchcock Clinic Lebanon, NH	B	$509,790	approved, future	CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM	202400379349100025
2023	Friends of the Israel Defense Forces New York, NY	B	$503,200	approved, future	IMPACT! SCHOLARSHIP PROGRAM	202400379349100025
2023	University of Notre Dame du Lac Notre Dame, IN	U	$503,082	approved, future	GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES	202400379349100025
2023	Villages of Hope Africa Society Mississauga	D	$502,010	paid	VILLAGES OF HOPE COMMUNITY DEVELOPMENT - FOOD PRODUCTION FACILITIES, WATER SUPPLY UPGRADE, AND EDUCATION FACILITIES.	202400379349100025
2023	Palo Alto Veterans Institute for Research Palo Alto, CA	B	$500,825	paid	CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE	202400379349100025
2023	Baylor College of Medicine Houston, TX	B	$500,180	approved, future	PILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE	202400379349100025
2023	Jdrf T1d Fund LLC Boston, MA	U	$500,000	paid	T1D FUND INITIATIVE TO DRIVE PHARMA INVESTMENT IN T1D	202400379349100025
2023	Tidepool Project Palo Alto, CA	B	$500,000	paid	TIDEPOOL DATA PLATFORM EXPANSION	202400379349100025
2023	Avera Mckennan for the Avera Mckennan Hospital and Uni Health Center Sioux Falls, SD	U	$500,000	paid	AVERA BEHAVIORAL HEALTH CENTER EXPANSION	202400379349100025
2023	Tidepool Project Palo Alto, CA	B	$500,000	paid	TIDEPOOL DATA PLATFORM EXPANSION	202400379349100025
2023	University of Cambridge Cambridge	U	$500,000	approved, future	CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2)	202400379349100025
2023	Jdrf T1d Fund LLC Boston, MA	U	$500,000	approved, future	T1D FUND INITIATIVE TO DRIVE PHARMA INVESTMENT IN T1D	202400379349100025
2023	Weizmann Institute of Science Rehovot	D	$500,000	approved, future	QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS	202400379349100025
2023	Ichud Hatzalah Israel 1221 (ra) Jerusalem	U	$499,890	paid	UNITED HATZALAH PRE-HOSPITAL EMS SIMULATION TRAINING EQUIPMENT	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$499,459	approved, future	INVESTIGATION OF ANTI-GM-CSF AUTOANTIBODIES AS A DISEASE DETERMINANT IN CROHNS DISEASE	202400379349100025
2023	Palo Alto Veterans Institute for Research Palo Alto, CA	B	$499,175	paid	CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE	202400379349100025
2023	University of Cambridge Cambridge	U	$496,568	paid	CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2)	202400379349100025
2023	The Chinese University of Hong Kong Shatin	U	$492,017	paid	MOTHER-TO-INFANT TRANSFER OF BACTERIOME, VIROME, FUNGOME AND METABOLOME IN HEALTH AND CROHN'S DISEASE (MOMMY-CD)	202400379349100025
2023	City Parks Foundation New York, NY	B	$491,131	paid	CATALYST: GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$488,364	approved, future	THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION	202400379349100025
2023	Washington University Saint Louis, MO	B	$488,300	approved, future	CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE	202400379349100025
2023	The University of Chicago Chicago, IL	U	$487,806	paid	A CELL ATLAS OF ILEAL COLONIC CROHN'S DISEASE	202400379349100025
2023	Georgia Tech Research Corporation Atlanta, GA	C	$485,617	approved, future	LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Georgia Tech Research Corporation Atlanta, GA	C	$485,616	approved, future	LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	The University of Chicago Chicago, IL	U	$484,264	paid	DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND	202400379349100025
2023	University of Massachusetts Medical School Worcester, MA	U	$482,825	paid	DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$481,111	paid	CGM MONITORING OF MATERNAL DYSGLYCEMIA	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$480,988	paid	PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)	202400379349100025
2023	Georgia Tech Research Corporation Atlanta, GA	C	$480,848	approved, future	LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Georgia Tech Research Corporation Atlanta, GA	C	$480,848	paid	LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$474,464	paid	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$474,464	paid	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$474,464	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	University of Massachusetts Medical School Worcester, MA	U	$473,409	approved, future	DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS	202400379349100025
2023	University of Miami Coral Gables, FL	U	$471,158	paid	A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$468,008	approved, future	VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$463,755	paid	A HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE	202400379349100025
2023	The Broad Institute Inc Cambridge, MA	B	$463,751	paid	A HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$463,512	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES	202400379349100025
2023	Cambridge University Hospitals Nhs Foundation Trust Cambridge	U	$462,323	approved, future	THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE	202400379349100025
2023	Glacial Ridge Hospital District Glenwood, MN	B	$459,547	paid	GLACIAL RIDGE HEALTH SYSTEM ULTRASOUND PROJECT	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$459,453	paid	THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM: BEYOND MALNUTRITION	202400379349100025
2023	Yehuda Abarbanel Government Hospital Bat Yam	U	$454,960	approved, future	MODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$454,441	approved, future	HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS	202400379349100025
2023	Hadassah Medical Organization Jerusalem	U	$454,400	approved, future	CREATING AND EQUIPPING A NEW COMPREHENSIVE DIAGNOSTIC AND INTERVENTIONAL IMAGING CENTER	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$452,465	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES	202400379349100025
2023	University of Exeter Exeter	U	$451,469	approved, future	EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2: FROM OBSERVATION TO MECHANISM	202400379349100025
2023	Australasian Gastro Intestinal Research Foundation Ltd Fitzroy	U	$450,697	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY TO IMPROVE HEALTH OUTCOMES	202400379349100025
2023	Sapir Academic College Regional Council Shaar Ha	U	$447,000	paid	PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$444,314	paid	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$444,247	paid	HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$444,246	approved, future	HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE	202400379349100025
2023	Yale University New Haven, CT	U	$443,827	paid	EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$439,601	approved, future	ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$438,659	approved, future	ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA	202400379349100025
2023	Medicines for Humanity Inc Rockland, MA	B	$436,472	approved, future	MAI MBELEKI II EXPANSION	202400379349100025
2023	The University of Queensland Brisbane	D	$435,713	approved, future	LIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET TYPE 1 DIABETES	202400379349100025
2023	Innodia Leuven	U	$434,183	approved, future	INNODIA NONPROFIT LAUNCH FOR THE CARE AND PREVENTION OF T1D.	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$433,333	paid	IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF PATIENT REGISTRY	202400379349100025
2023	University of Bristol Bristol	U	$431,779	approved, future	TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY	202400379349100025
2023	The Chinese University of Hong Kong Shatin	U	$430,508	paid	IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$429,646	approved, future	COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE	202400379349100025
2023	Trustees of Indiana University Bloomington, MI	U	$426,380	approved, future	COLLABORATIVE EFFORT TO VALIDATE MICRORNA AS BIOMARKERS OF T1D	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$421,681	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	Tidepool Project Palo Alto, CA	B	$421,085	paid	EXPANDING THE AVAILABILITY OF THE LOOP AID SYSTEM	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$419,010	paid	QUANTITATIVE PROTEOMIC PROFILING OF FIBROSTENOTIC CROHNS DISEASE PATIENTS	202400379349100025
2023	Montana Pediatrics Missoula, MT	C	$417,700	approved, future	CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$415,688	paid	NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$415,688	paid	NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$413,871	approved, future	EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$413,263	approved, future	COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE	202400379349100025
2023	Association of Diabetes Care & Education Specialists Chicago, IL	B	$413,127	paid	EXPANSION OF THE DANATECH PLATFORM TO IMPROVE T1D CARE	202400379349100025
2023	The Sonia Nabeta Foundation Inc New York, NY	C	$412,944	paid	PROJECT BODA-BODA	202400379349100025
2023	Medical University of South Carolina Charleston, SC	C	$412,500	approved, future	ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$410,774	approved, future	EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$409,388	paid	THE MELODY TRIAL: MODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S DISEASE	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$408,267	approved, future	HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS	202400379349100025
2023	University of Bristol Bristol	U	$407,937	paid	TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$407,000	approved, future	ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$407,000	approved, future	ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$407,000	paid	ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$406,254	paid	CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$404,688	approved, future	NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE	202400379349100025
2023	University of Exeter Exeter	U	$403,451	approved, future	STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$403,132	paid	POST-ACUTE STROKE CARE: IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$402,672	approved, future	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	Tri-County Hospital Inc Wadena, MN	U	$400,329	paid	TRI-COUNTY HEALTH CARE ULTRASOUND PROJECT	202400379349100025
2023	Simulation in Motion Montana Inc Helena, MT	B	$400,000	approved, future	SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY	202400379349100025
2023	Israel Antiquities Authority Jerusalem	U	$400,000	paid	THE JAY AND JEANIE SCHOTTENSTEIN NATIONAL CAMPUS FOR THE ARCHAEOLOGY OF ISRAEL	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$400,000	paid	EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$399,368	approved, future	2022-2024 TYPE 1 DIABETES CAMP INITIATIVE	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$399,368	approved, future	2022-2024 TYPE 1 DIABETES CAMP INITIATIVE	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$399,330	paid	ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$397,123	approved, future	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	University of Notre Dame du Lac Notre Dame, IN	U	$397,048	paid	DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$385,906	approved, future	FEASIBILITY OF OFF-SITE REMOTE CONTROL ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS: A PILOT ANIMAL FEASIBILITY STUDY	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$385,780	paid	USING NATURAL LANGUAGE PROCESSING OF CLINICAL DOCUMENTATION TO IMPROVE PERSONALIZATION OF CARE IN CROHN'S DISEASE	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$385,330	paid	IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS	202400379349100025
2023	Michigan State University East Lansing, MI	U	$382,594	paid	A C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$382,456	paid	HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE	202400379349100025
2023	Minnesota Rural Health Association Henning, MN	C	$378,700	approved, future	SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA	202400379349100025
2023	United Nations Development Programme New York, NY	C	$377,955	paid	INCREASING ACCESS TO HEALTHCARE FOR PEOPLE LIVING WITH DIABETES AND OTHER NCDS	202400379349100025
2023	Region Hovedstaden Hillerod	U	$375,228	approved, future	CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES?	202400379349100025
2023	International Bowel Ultrasound Group Ev Munster	U	$375,221	approved, future	DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE.	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$374,912	approved, future	IMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$374,591	approved, future	MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$374,591	paid	MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$374,591	approved, future	MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE	202400379349100025
2023	Children's Hospital Corporation Boston, MA	C	$374,591	paid	MOLECULAR AND SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$373,041	approved, future	MRI OF THE PANCREAS IN T1D	202400379349100025
2023	King's College London London	U	$369,984	approved, future	MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$369,880	approved, future	USING NATURAL LANGUAGE PROCESSING OF CLINICAL DOCUMENTATION TO IMPROVE PERSONALIZATION OF CARE IN CROHN'S DISEASE	202400379349100025
2023	Aphp St Antoine Hospital Paris	U	$367,129	approved, future	FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE)	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$364,763	approved, future	LONG-TERM RESPONSES TO SARS-COV-2 VACCINATION IN A DIVERSE INFLAMMATORY BOWEL DISEASE POPULATION: A MULTI-OMIC STUDY	202400379349100025
2023	Hebrew University of Jerusalem Jerusalem	D	$362,703	approved, future	METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE	202400379349100025
2023	Brigham and Women's Hospital Boston, MA	C	$360,771	paid	PASSIVE WIRELESS MONITORING OF CROHNS DISEASE PATIENTS TO TRACK DISEASE ACTIVITY AND PREDICT FLARES	202400379349100025
2023	University of Bristol Bristol	U	$358,900	approved, future	TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY	202400379349100025
2023	Parker Institute for Cancer Immunotherapy San Francisco, CA	B	$358,140	approved, future	UNDERSTANDING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$357,597	approved, future	EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$355,916	paid	PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK: THE PIONIR TRIAL (PREVENTING IBD ONSET IN INDIVIDUALS AT RISK)	202400379349100025
2023	University of Cambridge Cambridge	U	$353,223	approved, future	CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2)	202400379349100025
2023	The City of Hope Duarte, CA	U	$352,126	approved, future	GENETIC PROTECTION BY HLA-DQ6 IN T1D	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$351,258	approved, future	COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE	202400379349100025
2023	Massachusetts General Hospital Boston, MA	C	$350,278	paid	CROHN'S DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION AND BETTER TREATMENT	202400379349100025
2023	Children's Hospital of Philadelphia Philadelphia, PA	C	$349,553	paid	LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$348,000	paid	DEVELOPMENT OF AN INTESTINAL ULTRASOUND INDEX AND A HISTOPATHOLOGY INDEX FOR STRICTURING SMALL BOWEL CROHNS DISEASE	202400379349100025
2023	Behavioral Diabetes Institute San Diego, CA	B	$346,980	paid	CONSTRUCTION OF UPDATED T1-DIABETES DISTRESS SCALE (T1-DDS)	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$346,330	approved, future	IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS	202400379349100025
2023	St Vincent's Institute of Medical Research Melbourne	U	$343,506	paid	WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D?	202400379349100025
2023	Insulin for Life USA Inc Gainesville, FL	B	$341,606	approved, future	INSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$339,811	paid	EXERCISE EDUCATION AT NEW ONSET OF T1D	202400379349100025
2023	United Nations Development Programme New York, NY	C	$339,777	approved, future	INCREASING ACCESS TO HEALTHCARE FOR PEOPLE LIVING WITH DIABETES AND OTHER NCDS	202400379349100025
2023	Pioneer Medical Center Big Timber, MT	B	$339,522	paid	TELE-PHARMACY AT PIONEER MEDICAL CENTER	202400379349100025
2023	Washington University Saint Louis, MO	B	$338,970	approved, future	CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$337,310	approved, future	MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024)	202400379349100025
2023	Grand Itasca Clinic and Hospital Grand Rapids, MN	B	$335,587	paid	GRAND ITASCA CLINIC AND HOSPITAL ULTRASOUND PROJECT	202400379349100025
2023	The Regents of the University of California at Irvine Irvine, CA	C	$335,309	paid	DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$334,798	approved, future	COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$334,407	approved, future	DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES	202400379349100025
2023	The University of Chicago Chicago, IL	U	$333,042	approved, future	DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND	202400379349100025
2023	Healthpartners Institute Bloomington, MN	C	$332,200	paid	PILOT STUDY OF DIRECT INTEGRATION OF CONTINUOUS GLUCOSE MONITORING DATA INTO THE ELECTRONIC HEALTH RECORD TO IMPROVE DIABETES CARE	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$331,133	approved, future	THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$330,758	paid	DIABETIC KETOACIDOSIS TRENDS AND RESOURCE UTILIZATION AT DIAGNOSIS OF TYPE 1 DIABETES IN THE UNITED STATES	202400379349100025
2023	Washington University Saint Louis, MO	B	$330,000	approved, future	RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING	202400379349100025
2023	Washington University Saint Louis, MO	B	$330,000	approved, future	RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$330,000	paid	EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON INTENSIVE INSULIN THERAPY (IIT)	202400379349100025
2023	Washington University Saint Louis, MO	B	$330,000	paid	RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING	202400379349100025
2023	Crohn's and Colitis Uk Hatfield	U	$329,900	paid	SUPPORT FOR THE CROHNS AND COLITIS UK RESEARCH AWARDS	202400379349100025
2023	University of Miami Coral Gables, FL	U	$328,238	approved, future	THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE	202400379349100025
2023	University of Miami Coral Gables, FL	U	$326,055	approved, future	THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE	202400379349100025
2023	Ballad Research Institute San Diego, CA	B	$325,801	approved, future	CD127-HIGH T-CELL POPULATIONS AS BIOMARKERS	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$325,000	paid	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$325,000	paid	DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D	202400379349100025
2023	Medicines for Humanity Inc Rockland, MA	B	$322,909	approved, future	MAI MBELEKI II EXPANSION	202400379349100025
2023	University of Birmingham Birmingham	U	$322,498	paid	DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$322,462	approved, future	DISSEMINATION PILOT: THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM	202400379349100025
2023	Oregon Health & Science University Portland, OR	U	$322,462	approved, future	DISSEMINATION PILOT: THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM	202400379349100025
2023	The Rector and Visitors of the University of Virginia Charlottesville, VA	C	$321,984	approved, future	TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS	202400379349100025
2023	Insulin for Life USA Inc Gainesville, FL	B	$320,933	paid	INSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY	202400379349100025
2023	Palo Alto Veterans Institute for Research Palo Alto, CA	B	$318,978	approved, future	CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE	202400379349100025
2023	Minnesota Rural Health Association Henning, MN	C	$318,700	approved, future	SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA	202400379349100025
2023	Vayu Health Portola Valley, CA	B	$318,000	approved, future	VAYU FEASIBILITY PILOT	202400379349100025
2023	Baptist Medical Centre Nalerigu	U	$315,000	paid	EMERGENCY CENTRE AND DOCTOR HOUSING DEVELOPMENT	202400379349100025
2023	Emory University Atlanta, GA	U	$313,686	approved, future	CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION	202400379349100025
2023	University of Massachusetts Medical School Worcester, MA	U	$311,133	paid	DIETA ANTI-INFLAMATORIA: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS	202400379349100025
2023	Pulitzer Center On Crisis Reporting Washington, DC	C	$310,123	approved, future	BUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION	202400379349100025
2023	Nebraska Dept of Health & Human Services Division of Public Health Lincoln, NE	U	$309,887	approved, future	NEBRASKA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$308,267	approved, future	PRECLINICAL DEVELOPMENT OF A MONOCLONAL ANTIBODY TO SERPINB13	202400379349100025
2023	King's College London London	U	$307,779	approved, future	HYPO - RESOLVE - EVALUATION OF BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA	202400379349100025
2023	The Tel Aviv Jaffa Academic College Tel Aviv Yaffo	U	$306,724	paid	SCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX (HAREDI) MEN PURSUING B.S. DEGREES IN NURSING	202400379349100025
2023	The University of Chicago Chicago, IL	U	$305,353	paid	IMMUNO-PHARMACOGENOMICS TO UNDERSTAND AND PREDICT RESPONSE TO BIOLOGICS IN CROHN'S DISEASE	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$305,349	approved, future	NEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE	202400379349100025
2023	Sapir Academic College Regional Council Shaar Ha	U	$303,000	approved, future	PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING	202400379349100025
2023	Emory University Atlanta, GA	U	$302,430	approved, future	CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION	202400379349100025
2023	Pulitzer Center On Crisis Reporting Washington, DC	C	$302,170	paid	BUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$300,000	paid	MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$300,000	paid	ADAS FOCUS ON FELLOWS, DIABETES IS PRIMARY, AND PROFESSIONAL MEMBERSHIP INTEREST GROUPS PROJECTS (2020-2022)	202400379349100025
2023	Massachusetts Institute of Technology Cambridge, MA	B	$300,000	approved, future	COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS	202400379349100025
2023	Massachusetts Institute of Technology Cambridge, MA	B	$300,000	paid	COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS	202400379349100025
2023	Massachusetts Institute of Technology Cambridge, MA	B	$300,000	approved, future	COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$300,000	approved, future	MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL	202400379349100025
2023	Nuru International Washington, CA	U	$300,000	paid	EXPANDING AND SUSTAINING AGRIBUSINESS IMPACT IN ETHIOPIA	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$300,000	approved, future	MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL	202400379349100025
2023	Yale University New Haven, CT	U	$298,606	approved, future	EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE	202400379349100025
2023	St Vincent's Institute of Medical Research Melbourne	U	$298,224	approved, future	WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D?	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$297,898	approved, future	COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE: THE OATS STUDY	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$297,612	approved, future	IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE	202400379349100025
2023	New Destiny Housing Corporation New York, NY	B	$296,096	paid	PILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS	202400379349100025
2023	University of Miami Coral Gables, FL	U	$295,977	paid	DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES	202400379349100025
2023	Universite Libre de Bruxelles Brussels	U	$295,566	paid	GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$293,370	approved, future	THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE	202400379349100025
2023	Palo Alto Veterans Institute for Research Palo Alto, CA	B	$292,821	approved, future	CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE	202400379349100025
2023	Palo Alto Veterans Institute for Research Palo Alto, CA	B	$292,821	approved, future	CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE	202400379349100025
2023	Cambridge University Hospitals Nhs Foundation Trust Cambridge	U	$292,476	approved, future	THE UK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE	202400379349100025
2023	Arad Municipality Arad	U	$290,000	approved, future	ARAD OCCUPATIONAL REHABILITATION CENTER	202400379349100025
2023	Governing Council of the University of Toronto Toronto	D	$289,960	paid	DEVELOPMENT OF A GLUCOSE RESPONSIVE GLUCAGON (GRG) MICRONEEDLE PATCH FOR THE PREVENTION OF HYPOGLYCEMIA	202400379349100025
2023	King's College London London	U	$288,101	paid	IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$286,838	approved, future	IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CROHNS PATIENTS IN CANADA	202400379349100025
2023	University of Miami Coral Gables, FL	U	$286,197	approved, future	DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES	202400379349100025
2023	Ely-Bloomenson Community Hospital Ely, MN	B	$285,654	paid	ELY-BLOONEMSON COMMUNITY HOSPITAL ULTRASOUND REVITALIZATION PROJECT	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$285,463	paid	THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$285,463	paid	THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE	202400379349100025
2023	Herlev Og Gentofte Hospital Herlev	U	$285,339	approved, future	TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$285,177	paid	DEVELOPING OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES	202400379349100025
2023	Trustees of the University of Pennsylvania Philadelphia, PA	B	$285,079	approved, future	THE ULTRA PROCESSED WESTERN DIET, THE GUT MICROBIOME, AND DIETARY XENOBIOTIC EXPOSURE IN CROHNS DISEASE	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$284,646	approved, future	IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE	202400379349100025
2023	Montana Pediatrics Missoula, MT	C	$284,500	paid	CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D	202400379349100025
2023	University of Oulu Oulu	U	$284,289	approved, future	MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$283,542	approved, future	EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY	202400379349100025
2023	Emory University Atlanta, GA	U	$283,099	approved, future	CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$282,554	paid	BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHNS DISEASE	202400379349100025
2023	Appleton Area Health Appleton, MN	U	$281,865	paid	APPLETON AREA HEALTH ULTRASOUND INITIATIVE	202400379349100025
2023	New Destiny Housing Corporation New York, NY	B	$281,806	approved, future	PILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$280,115	approved, future	SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$279,999	approved, future	ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA	202400379349100025
2023	King's College London London	U	$278,644	approved, future	CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS	202400379349100025
2023	American Diabetes Association Inc Arlington, VA	B	$278,350	approved, future	MENTAL HEALTH EDUCATION PROGRAM PHASE 2 (2022 2024)	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$275,688	paid	IMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$275,588	approved, future	IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CROHNS PATIENTS IN CANADA	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$275,000	paid	DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA	202400379349100025
2023	The University of Texas Southwestern Medical Center Dallas, TX	D	$275,000	paid	IMMUNE CHECKPOINT ENGINEERED BETA CELL AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF TYPE I DIABETES	202400379349100025
2023	The University of Texas Southwestern Medical Center Dallas, TX	D	$275,000	approved, future	IMMUNE CHECKPOINT ENGINEERED BETA CELL AS AN ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF TYPE I DIABETES	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$275,000	approved, future	DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA	202400379349100025
2023	Vanderbilt University Nashville, TN	C	$275,000	paid	NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING	202400379349100025
2023	Vanderbilt University Nashville, TN	C	$275,000	approved, future	NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING	202400379349100025
2023	Medical University of South Carolina Charleston, SC	C	$275,000	approved, future	ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$275,000	approved, future	DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA	202400379349100025
2023	Vanderbilt University Nashville, TN	C	$275,000	approved, future	NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING	202400379349100025
2023	President and Fellows of Harvard College Cambridge, MA	B	$274,787	paid	PRE-SYMPTOMATIC AUTOANTIBODY AND VIRAL PROFILE OF US MILITARY PERSONNEL WITH ADULT-ONSET TYPE 1 DIABETES	202400379349100025
2023	Children's Hospital of Philadelphia Philadelphia, PA	C	$272,676	paid	A CROHNS DISEASE EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM	202400379349100025
2023	Association Sante Diabte Grenoble	U	$272,362	paid	IMPROVE THE MANAGEMENT OF DIABETES AND THE SUPPORT TO PEOPLE AFFECTED BY THE DISEASE IN BURKINA FASO, MALI AND THE UNION OF COMOROS	202400379349100025
2023	King's College London London	U	$270,269	paid	CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS	202400379349100025
2023	Dartmouth- Hitchcock Clinic Lebanon, NH	B	$269,933	paid	CAPACITY BUILDING FOR DARTMOUTH HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$269,368	approved, future	PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$269,368	approved, future	PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)	202400379349100025
2023	Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv	U	$268,340	approved, future	IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$268,151	paid	INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO BETTER UNDERSTAND THE CAUSES OF, AND HETEROGENEITY IN, CROHN'S DISEASE	202400379349100025
2023	Alimentiv Inc London	U	$267,835	approved, future	DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES	202400379349100025
2023	Hannoversche Kinderheilanstalt Hannover	U	$267,694	paid	FR1DA IN NORTHERN GERMANY: PRE-SYMPTOMATIC TYPE 1 DIABETES TESTING IN CHILDREN	202400379349100025
2023	Critical Path Institute Tucson, AZ	B	$266,741	paid	T1D CONSORTIUM 2.0	202400379349100025
2023	Critical Path Institute Tucson, AZ	B	$266,741	approved, future	T1D CONSORTIUM 2.0	202400379349100025
2023	Critical Path Institute Tucson, AZ	B	$266,741	approved, future	T1D CONSORTIUM 2.0	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$266,200	approved, future	FAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$266,200	paid	FAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$264,341	paid	SINGLE PERSISTENT ISLET AUTOANTIBODY (SPIA) PHENOTYPE: PERSONALIZED RISK ASSESSMENT	202400379349100025
2023	Crohn's and Colitis Uk Hatfield	U	$263,570	paid	SUPPORT FOR CROHN'S AND COLITIS UK'S MULTI-CHANNEL HELPLINE SERVICE	202400379349100025
2023	University of Oulu Oulu	U	$263,104	approved, future	MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING	202400379349100025
2023	Consorci Institut D'investigaciones Biomdicas August Pi I Sunyer Barcelona	U	$261,948	paid	EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING	202400379349100025
2023	T1d Exchange Inc Boston, MA	U	$261,908	paid	A DATA DRIVEN APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH TYPE 1 DIABETES	202400379349100025
2023	Consorci Institut D'investigaciones Biomdicas August Pi I Sunyer Barcelona	U	$261,570	approved, future	EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING	202400379349100025
2023	Alimentiv Inc London	U	$259,951	approved, future	DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD AND IMPROVE HEALTH OUTCOMES	202400379349100025
2023	The University of Adelaide Adelaide	U	$256,408	paid	ENDIA EXPANDED SUPPORT	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$256,190	paid	VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$256,007	paid	EXERCISE EDUCATION AT NEW ONSET OF T1D	202400379349100025
2023	St Vincent's Institute of Medical Research Melbourne	U	$255,857	approved, future	WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D?	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$255,521	paid	IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE	202400379349100025
2023	The Tel Aviv Jaffa Academic College Tel Aviv Yaffo	U	$253,818	approved, future	SCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX (HAREDI) MEN PURSUING B.S. DEGREES IN NURSING	202400379349100025
2023	Crohn's and Colitis Canada Toronto	U	$253,783	paid	IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE	202400379349100025
2023	Lake View Memorial Hospital Foundation of Northeast Minnesota Two Harbors, MN	C	$253,075	paid	LAKE VIEW HOSPITAL ULTRASOUND PROJECT	202400379349100025
2023	Swift County-Benson Hospital Benson, MN	C	$252,828	paid	SWIFT COUNTY BENSON HOSPITAL ULTRASOUND PROJECT	202400379349100025
2023	The Chinese University of Hong Kong Shatin	U	$251,789	paid	IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$251,522	approved, future	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$250,000	approved, future	MILITARY SCIENCES MEDICAL TRAINING 2022-2024	202400379349100025
2023	The Milken Institute Santa Monica, CA	B	$250,000	approved, future	FASTERCURES LEADERSLINK PROGRAM EXPANSION	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$250,000	paid	SUPPORT FOR T1D TRANSITION PROGRAMS	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$250,000	paid	PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES	202400379349100025
2023	The Milken Institute Santa Monica, CA	B	$250,000	approved, future	FASTERCURES LEADERSLINK PROGRAM EXPANSION	202400379349100025
2023	The Milken Institute Santa Monica, CA	B	$250,000	paid	FASTERCURES LEADERSLINK PROGRAM EXPANSION	202400379349100025
2023	The Chinese University of Hong Kong Shatin	U	$249,337	approved, future	IBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$248,256	approved, future	DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$248,256	approved, future	DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$247,654	approved, future	QUANTITATIVE PROTEOMIC PROFILING OF FIBROSTENOTIC CROHNS DISEASE PATIENTS	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$246,663	paid	AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT	202400379349100025
2023	Katholieke Universiteit Leuven Leuven	U	$246,662	approved, future	AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT	202400379349100025
2023	Technische Universitaet Muenchen Munchen	U	$245,905	paid	METAGENOMIC PILOT PROJECT	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$244,860	approved, future	THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$244,860	approved, future	THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$244,200	paid	DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$244,200	paid	DEVELOPMENT OF AN ADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GUT CELL ATLAS	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$243,216	paid	THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$243,216	approved, future	THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$243,196	approved, future	SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE	202400379349100025
2023	University of Miami Coral Gables, FL	U	$242,826	approved, future	DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$242,153	paid	THE INFLAMMATORY BOWEL DISEASE MEDITERRANEAN DIET (IBDMED) MICROBIOME-TARGETING NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL AND PREVENTION	202400379349100025
2023	Project Nyame Nsa Ltd Manhasset, NY	U	$241,600	paid	PROJECT NYAME NSA ZAMBIA EXPANSION	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$241,173	approved, future	PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)	202400379349100025
2023	The Regents of the University of California San Francisco San Francisco, CA	U	$241,173	approved, future	PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO)	202400379349100025
2023	United Hospital District Inc Blue Earth, MN	B	$240,907	paid	UNITED HOSPITAL DISTRICT INC. ULTRASOUND PROJECT	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$239,587	paid	SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE	202400379349100025
2023	University of Pittsburgh Pittsburgh, PA	B	$237,102	approved, future	SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$236,313	approved, future	THE MILESTONE INITIATIVE: EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA	202400379349100025
2023	Children's Hospital Medical Center Cincinnati, OH	B	$235,507	paid	PRECISION CROHNS DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS	202400379349100025
2023	Phillips County Hospital Association Malta, MT	B	$234,588	paid	TELE-EMERGENCY AND TELE-PHARMACY AT PHILLIPS COUNTY	202400379349100025
2023	Vayu Health Portola Valley, CA	B	$233,495	approved, future	VAYU FEASIBILITY PILOT	202400379349100025
2023	University of Birmingham Birmingham	U	$233,307	approved, future	DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES: AN EXPERIMENTAL MEDICINE STUDY	202400379349100025
2023	University at Buffalo Pediatric Associates P C Buffalo, NY	D	$233,094	approved, future	FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS	202400379349100025
2023	Aitkin Community Hospital Inc Aitkin, MN	B	$233,092	paid	AITKIN COMMUNITY HOSPITAL/ RIVERWOOD HEALTHCARE CENTER ULTRASOUND PROJECT	202400379349100025
2023	Jdrf Australia Sydney	U	$232,577	paid	ENDIA EARLY TO MID CAREER SCIENCE ACCELERATOR AWARDS 2021	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$232,525	approved, future	ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$232,068	paid	FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$231,849	paid	INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO BETTER UNDERSTAND THE CAUSES OF, AND HETEROGENEITY IN, CROHN'S DISEASE	202400379349100025
2023	Shatterproof a Nonprofit Corp Norwalk, CT	U	$230,000	paid	GENERAL OPERATING SUPPORT	202400379349100025
2023	Uppsala Universitet Uppsala	U	$229,347	approved, future	ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION	202400379349100025
2023	Children's Hospital of Philadelphia Philadelphia, PA	C	$228,375	approved, future	LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$228,294	approved, future	COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE: THE CURE STUDY	202400379349100025
2023	Ideoorg San Francisco, CA	U	$227,950	paid	HUMAN-CENTERED DESIGN STUDY OF TYPE 1 DIABETES IN MEDICALLY UNDERSERVED COMMUNITIES IN THE U.S.	202400379349100025
2023	Tear Australia Blackburn	U	$224,000	paid	FACILITATE SECURE ENVIRONMENTS FOR AMPLIFIED NUTRITION	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$221,931	approved, future	SCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$221,420	approved, future	INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE	202400379349100025
2023	Minnesota Rural Health Association Henning, MN	C	$220,100	paid	SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA	202400379349100025
2023	The Max Stern Academic College of Emek Yezreel Ltd (cc) Yezreel Valley	U	$220,000	paid	OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN-ISRAELIS PURSUING NURSING DEGREES	202400379349100025
2023	The Max Stern Academic College of Emek Yezreel Ltd (cc) Yezreel Valley	U	$220,000	approved, future	OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN-ISRAELIS PURSUING NURSING DEGREES	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$220,000	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$220,000	approved, future	VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD): PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES	202400379349100025
2023	University of Washington Seattle, WA	B	$220,000	paid	PATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES	202400379349100025
2023	Center for Excellence in Health Care Journalism Columbia, MO	C	$219,995	paid	TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND RESOURCES FOR HEALTH REPORTING	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$219,514	approved, future	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	Minnesota State Colleges and Universities St Paul, MN	U	$217,428	approved, future	EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA	202400379349100025
2023	Herlev Og Gentofte Hospital Herlev	U	$217,256	approved, future	UTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS	202400379349100025
2023	Winona Health Services Winona, MN	B	$216,473	paid	ULTRASOUND REVITALIZATION PROJECT AT WINONA HEALTH	202400379349100025
2023	County of Murray Slayton, MN	U	$216,230	paid	ULTRASOUND REVITALIZATION PROJECT	202400379349100025
2023	Healthpartners Rc Olivia, MN	C	$216,022	paid	OLIVIA HOSPITAL & CLINIC ULTRASOUND PROJECT	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$216,002	paid	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	Icahn School of Medicine at Mount Sinai New York City, NY	B	$214,842	approved, future	STUDY TO EVALUATE SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC SUBJECTS WITH MILD-TO-MODERATE CROHN'S DISEASE	202400379349100025
2023	Universite Libre de Bruxelles Brussels	U	$213,602	approved, future	GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING	202400379349100025
2023	Universite Libre de Bruxelles Brussels	U	$213,582	approved, future	GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$212,881	approved, future	HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE	202400379349100025
2023	Sanford Research Sioux Fall, SD	C	$212,565	paid	SANFORD PLEDGE: PHASES 1 AND 2	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$211,815	approved, future	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	The Rector and Visitors of the University of Virginia Charlottesville, VA	C	$211,526	paid	TYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS	202400379349100025
2023	Technische Universitat Dresden Dresden	U	$210,829	approved, future	GENOMIC INFLUENCE OF MATERNAL TYPE 1 DIABETES - UNDERSTANDING PROTECTION AGAINST TYPE 1 DIABETES	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$210,638	paid	COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE	202400379349100025
2023	Asian Health Care Foundation Hyderabad	U	$210,551	paid	IMPROVING ACCESS TO DIAGNOSTICS FOR CROHN'S DISEASE PATIENTS LIVING BELOW THE POVERTY LINE IN SOUTHERN INDIA	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$210,228	paid	SPATIALLY RESOLVED GENOMIC PROFILING AT SUB-CELLULAR RESOLUTION AND HIGH THROUGHPUT OF CROHNS DISEASE TISSUE BIOPSIES	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$209,222	approved, future	HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE	202400379349100025
2023	King's College London London	U	$208,787	approved, future	CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6+) SUBJECTS	202400379349100025
2023	Cook County Hospital District Grand Marais, MN	D	$207,235	paid	NORTH SHORE HEALTH ULTRASOUND PROJECT	202400379349100025
2023	Association Sante Diabte Grenoble	U	$205,984	approved, future	IMPROVE THE MANAGEMENT OF DIABETES AND THE SUPPORT TO PEOPLE AFFECTED BY THE DISEASE IN BURKINA FASO, MALI AND THE UNION OF COMOROS	202400379349100025
2023	New York University New York, NY	B	$205,596	paid	EVALUATION OF PILOT INTERVENTIONS FOR THE COLLABORATIVE FOR HOMELESS HEALTHCARE	202400379349100025
2023	Minnesota State Colleges and Universities St Paul, MN	U	$205,285	approved, future	EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$204,837	paid	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	University of Iowa Iowa City, IA	U	$204,566	approved, future	SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION	202400379349100025
2023	University of Utah Salt Lake City, UT	B	$203,988	paid	ANTI-PHAGE ANTIBODIES IN STRATIFYING CROHNS DISEASE DIAGNOSIS AND TREATMENT RESPONSE	202400379349100025
2023	Duke University Durham, NC	B	$203,497	approved, future	AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AS A SAFEGUARD AGAINST INSULIN-INDUCED HYPOGLYCEMIA IN T1D	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$202,791	approved, future	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	Weill Medical College of Cornell University New York, NY	U	$202,620	approved, future	TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$202,073	approved, future	EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D	202400379349100025
2023	University of Texas System for the University of Texas at Austin Austin, TX	U	$200,927	approved, future	INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN	202400379349100025
2023	University of Texas System for the University of Texas at Austin Austin, TX	U	$200,927	approved, future	INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN	202400379349100025
2023	Cedars-Sinai Medical Center Los Angeles, CA	B	$200,041	approved, future	A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY	202400379349100025
2023	Ideoorg San Francisco, CA	U	$200,000	paid	HUMAN-CENTERED DESIGN STUDY OF TYPE 1 DIABETES IN MEDICALLY UNDERSERVED COMMUNITIES IN THE U.S.	202400379349100025
2023	Jdrf International New York, NY	U	$200,000	paid	CO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR	202400379349100025
2023	Jdrf International New York, NY	U	$200,000	approved, future	CO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR	202400379349100025
2023	American Heart Association Inc Dallas, TX	B	$200,000	paid	AMERICAN BOARD OF TELEHEALTH PROGRAM EXPANSION	202400379349100025
2023	Shatterproof a Nonprofit Corp Norwalk, CT	U	$200,000	approved, future	GENERAL OPERATING SUPPORT	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$200,000	approved, future	ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES	202400379349100025
2023	Youth Development Organization Inc Lawrence, MA	B	$200,000	paid	CAPACITY BUILDING PROJECT SUPPORT 2022	202400379349100025
2023	Youth Development Organization Inc Lawrence, MA	B	$200,000	approved, future	CAPACITY BUILDING PROJECT SUPPORT 2022	202400379349100025
2023	For Inspiration and Recognition of Science and Technology (first) Manchester, NH	B	$200,000	paid	FIRST SENIOR MENTOR PROGRAM	202400379349100025
2023	Citizens Housing and Planning Council of New York Inc New York, NY	B	$200,000	paid	EDUCATION FOR NYC POLICYMAKERS ON HOUSING INITIATIVES TO IMPROVE HEALTH	202400379349100025
2023	Northern Westchester Hospital Association Mount Kisco, NY	C	$200,000	paid	MATERNAL CHILD HEALTH UNIT FACILITIES RENOVATION	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$200,000	approved, future	SUPPORT FOR T1D TRANSITION PROGRAMS	202400379349100025
2023	University of Iowa Iowa City, IA	U	$199,968	approved, future	SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION	202400379349100025
2023	University of Texas System for the University of Texas at Austin Austin, TX	U	$198,646	approved, future	INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN	202400379349100025
2023	University of Texas System for the University of Texas at Austin Austin, TX	U	$198,646	approved, future	INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN	202400379349100025
2023	The City of Hope Duarte, CA	U	$197,874	paid	GENETIC PROTECTION BY HLA-DQ6 IN T1D	202400379349100025
2023	Board of Regents Nevada System of Higher Education Reno, NV	B	$197,208	approved, future	ULTRASOUND TRAINING INITIATIVE IN NEVADA	202400379349100025
2023	Board of Regents Nevada System of Higher Education Reno, NV	B	$197,208	approved, future	ULTRASOUND TRAINING INITIATIVE IN NEVADA	202400379349100025
2023	University of Texas System for the University of Texas at Austin Austin, TX	U	$196,411	approved, future	INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$196,089	approved, future	EUROPEAN PRE-T1D REGISTRY	202400379349100025
2023	King's College London London	U	$195,494	approved, future	IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL	202400379349100025
2023	University of Iowa Iowa City, IA	U	$194,408	paid	SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION	202400379349100025
2023	Madelia Health Madelia, MN	B	$193,530	paid	MADELIA HEALTH ULTRASOUND PROJECT	202400379349100025
2023	White Earth Health Center Ogema, MN	U	$192,403	paid	NAYTAHWAUSH CLINIC ULTRASOUND PROJECT	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$191,883	approved, future	THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE	202400379349100025
2023	Cass Lake Indian Hospital Cass Lake, MN	U	$191,462	paid	CASS LAKE INDIAN HOSPITAL ULTRASOUND PROJECT	202400379349100025
2023	De la Salle Solidariet Internazionale Onlus Rome	U	$191,462	paid	ETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY	202400379349100025
2023	Welia Health Mora, MN	B	$191,358	paid	WELIA HEALTH ULTRASOUND EQUIPMENT PROJECT	202400379349100025
2023	Regents of the University of Minnesota Minneapolis, MN	U	$190,677	approved, future	DEVELOPING OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES	202400379349100025
2023	University of Exeter Exeter	U	$190,161	paid	ADVANCING B-CELL SPECIFIC THERAPY BY IDENTIFYING B-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS	202400379349100025
2023	Royal Institution for the Advancement of Learning-Mcgill Uni Montreal	D	$189,596	paid	THE HUMAN CELL ATLAS: ETHICS AND DATA GOVERNANCE	202400379349100025
2023	White Earth Health Center Ogema, MN	U	$188,669	paid	WHITE EARTH INDIAN HEALTH CENTER ULTRASOUND PROJECT	202400379349100025
2023	The Sheba Fund for Health Services and Research (ra) Ramat Gan	U	$188,118	approved, future	ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM: CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD)	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$188,007	approved, future	EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY	202400379349100025
2023	Washington University Saint Louis, MO	B	$187,844	paid	CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$187,672	approved, future	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$187,370	paid	EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE	202400379349100025
2023	Regents of the University of Michigan Ann Arbor, MI	C	$187,370	approved, future	EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE	202400379349100025
2023	Iowa Department of Public Health Des Moines, IA	U	$186,944	paid	IOWA FIRST RESPONDER AED INITIATIVE	202400379349100025
2023	Glencoe Regional Health Services Glencoe, MN	B	$186,843	paid	ULTRASOUND REVITALIZATION PROJECT	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$186,777	paid	THE CHANGING EPIDEMIOLOGY AND DEMOGRAPHICS OF CROHNS DISEASE IN THE WESTERN WORLD OVER THE NEXT DECADE	202400379349100025
2023	Governing Council of the University of Toronto Toronto	D	$185,460	paid	DEVELOPMENT OF A GLUCOSE RESPONSIVE GLUCAGON (GRG) MICRONEEDLE PATCH FOR THE PREVENTION OF HYPOGLYCEMIA	202400379349100025
2023	The Sderot Development Foundation Sderot	U	$184,286	paid	SDEROT RESILIENCE COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$183,039	paid	EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$182,168	approved, future	ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$182,000	paid	MILITARY SCIENCES MEDICAL TRAINING 2022-2024	202400379349100025
2023	The University of Adelaide Adelaide	U	$181,471	approved, future	ENDIA SCIENCE CONTINUATION	202400379349100025
2023	Red Lake Indian Health Services Red Lake, MN	U	$179,899	paid	RED LAKE IHS HOSPITAL ULTRASOUND PROJECT	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$179,714	approved, future	UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES.	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$178,540	approved, future	FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$178,454	approved, future	EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$177,281	paid	COVID-19 VACCINE RESPONSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE	202400379349100025
2023	Consorci Institut D'investigaciones Biomdicas August Pi I Sunyer Barcelona	U	$177,122	paid	EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING	202400379349100025
2023	University of Glasgow Court Glasgow	U	$176,239	approved, future	COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE: THE BIOPIC STUDY	202400379349100025
2023	Jdrf International New York, NY	U	$175,000	approved, future	FOCUSING DEVELOPMENT EFFORTS TO ACCELERATE COMMERCIAL RELEASE OF CLOSED LOOP SENSOR SYSTEM	202400379349100025
2023	International Falls Memorial Hospital Association International Falls, MN	B	$173,810	paid	RAINY LAKE MEDICAL CENTER ULTRASOUND PROJECT	202400379349100025
2023	Albert Einstein College of Medicine Bronx, NY	B	$173,613	approved, future	PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY	202400379349100025
2023	Universitair Medisch Centrum Utrecht Utrecht	U	$173,250	approved, future	EPITHELIAL-BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD	202400379349100025
2023	Universitair Medisch Centrum Utrecht Utrecht	U	$173,250	approved, future	EPITHELIAL-BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD	202400379349100025
2023	International Bowel Ultrasound Group Ev Munster	U	$172,967	paid	POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES: INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY	202400379349100025
2023	Shatterproof a Nonprofit Corp Norwalk, CT	U	$170,000	approved, future	GENERAL OPERATING SUPPORT	202400379349100025
2023	Albert Einstein College of Medicine Bronx, NY	B	$168,556	approved, future	PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY	202400379349100025
2023	Wyoming Department of Health Cheyenne, WY	U	$167,693	paid	WYOMING FIRST RESPONDER AED PROJECT	202400379349100025
2023	Friends of the Israel Defense Forces New York, NY	B	$165,600	paid	IMPACT! SCHOLARSHIP PROGRAM	202400379349100025
2023	Institut Integrated Biobank of Luxembourg Dudelange	U	$164,873	approved, future	BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL	202400379349100025
2023	Institut Nationale de la Sante Et de la Recherche Medicale Paris	U	$164,338	paid	FROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES: MECHANISTIC CD8+ T-CELL BIOMARKERS OF PROGRESSION	202400379349100025
2023	Albert Einstein College of Medicine Bronx, NY	B	$163,648	paid	PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D PILOT STUDY	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$163,405	approved, future	ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES	202400379349100025
2023	The University of Adelaide Adelaide	U	$163,010	approved, future	ENDIA EXPANDED SUPPORT	202400379349100025
2023	The Jewish Agency for Israel Jerusalem	D	$161,477	approved, future	THE JEWISH AGENCY SECURITY FUND (THE FUND)	202400379349100025
2023	Jaeb Center for Health Research Foundation Inc Tampa, FL	C	$159,838	approved, future	EXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY	202400379349100025
2023	The University of Edinburgh Edinburgh	U	$159,623	approved, future	UNDERSTANDING ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN TYPE 1 DIABETES.	202400379349100025
2023	Chancellor Masters & Scholars of the University of Oxford Oxford	D	$159,416	paid	INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE	202400379349100025
2023	University of Exeter Exeter	U	$157,744	paid	STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$157,700	approved, future	DIABETIC KETOACIDOSIS TRENDS AND RESOURCE UTILIZATION AT DIAGNOSIS OF TYPE 1 DIABETES IN THE UNITED STATES	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$156,725	paid	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	American Gastroenterological Association Institute Bethesda, MD	B	$155,930	paid	STRATEGIES FOR INDIVIDUALIZING MANAGEMENT OF INFLAMMATORY BOWEL DISEASE FOR ADVANCED PRACTICE PROVIDERS	202400379349100025
2023	The Cleveland Clinic Foundation Cleveland, OH	C	$155,544	paid	STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM	202400379349100025
2023	The Regents of the University of Colorado Denver Aurora, CO	D	$155,376	paid	TRIAL OF EARLY INITIATION OF CGM-GUIDED INSULIN THERAPY IN T1D	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$153,920	approved, future	NEVADA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Centre Hospitalier Regional de Nancy Nancy	U	$153,102	approved, future	PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE: THE NEMO PROJECT	202400379349100025
2023	Children's Hunger Fund Sylmar, CA	B	$151,800	paid	MERCY NETWORK FOOD SUPPORT IN ETHIOPIA AND ZAMBIA	202400379349100025
2023	Mayo Clinic Rochester, MN	U	$151,705	approved, future	DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES	202400379349100025
2023	South Lincoln Hospital District Kemmerer, WY	D	$151,487	paid	TELE-EMERGENCY AT SOUTH LINCOLN MEDICAL CENTER	202400379349100025
2023	Board of Trustees of the Leland Stanford Junior University Stanford, CA	B	$150,162	paid	LONGITUDINAL STUDY OF MYOELECTRIC GUTPRINT OF HEALTHY CONTROLS AND CROHN'S DISEASE PATIENTS DURING FLARES AND IN REMISSION	202400379349100025
2023	The Trustees of Columbia University in the City of New York New York, NY	U	$150,000	approved, future	SUPPORT FOR T1D TRANSITION PROGRAMS	202400379349100025
2023	Jdrf International New York, NY	U	$150,000	approved, future	HELMSLEY AND JDRF CO-FUNDED WORKSHOPS	202400379349100025
2023	Kyler Cares Foundation New Orleans, LA	C	$150,000	paid	GENERAL OPERATING SUPPORT	202400379349100025
2023	National Academy of Sciences Washington, DC	C	$150,000	approved, future	STRENGTHENING MINORITY SERVING INSTITUTIONS	202400379349100025
2023	Jdrf International New York, NY	U	$150,000	approved, future	HELMSLEY AND JDRF CO-FUNDED WORKSHOPS	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$149,167	paid	DIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3	202400379349100025
2023	Beyond Type 1 San Mateo, CA	D	$149,166	approved, future	DIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3	202400379349100025
2023	Shaare Zedek Medical Center Jerusalem	D	$148,825	paid	PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK: THE PIONIR TRIAL (PREVENTING IBD ONSET IN INDIVIDUALS AT RISK)	202400379349100025
2023	Universite Catholique de Louvain Louvainlaneuve	U	$147,087	paid	STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN WITH T1D	202400379349100025
2023	Jdrf International New York, NY	U	$147,000	approved, future	FOCUSING DEVELOPMENT EFFORTS TO ACCELERATE COMMERCIAL RELEASE OF CLOSED LOOP SENSOR SYSTEM	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$146,933	paid	COMBINATORIAL SINGLE CELL STRATEGIES FOR A CROHN'S DISEASE GUT CELL ATLAS	202400379349100025
2023	Warren Community Hospital Inc Warren, MN	B	$146,513	paid	NORTH VALLEY HEALTH CENTER ULTRASOUND PROJECT	202400379349100025
2023	North Dakota Department of Health Bismarck, ND	U	$146,189	paid	NORTH DAKOTA LAW ENFORCEMENT AED PROJECT	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$145,605	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT	202400379349100025
2023	Genome Research Limited for the Wellcome Sanger Institute Cambridge	U	$143,892	approved, future	MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE	202400379349100025
2023	Helmholtz Zentrum Munchen (gmbh) Neuherberg	U	$142,350	paid	EUROPEAN PRE-T1D REGISTRY	202400379349100025
2023	Bridges to Prosperity Inc Denver, CO	D	$142,110	paid	ETHIOPIA ASSESSMENT	202400379349100025
2023	Bridges to Prosperity Inc Denver, CO	D	$142,110	paid	ZAMBIA ASSESSMENT	202400379349100025
2023	Pipestone County Medical Center Pipestone, MN	U	$141,701	paid	PCMC ULTRASOUND REVITALIZATION PROJECT.	202400379349100025
2023	Crohn's Colitis Cure Sydney	U	$141,158	paid	DEVELOPMENT OF A PEDIATRIC-SPECIFIC CROHNS DISEASE ELECTRONIC MEDICAL RECORD TO DRIVE CARE CONSISTENCY AND ENHANCE TRANSITIONS IN CARE	202400379349100025
2023	Vanderbilt University Medical Center Nashville, TN	C	$140,766	paid	ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES	202400379349100025
2023	Banner Health DBA Banner Churchill Community Hospital Fallon, NV	U	$139,574	paid	BANNER CHURCHILL COMMUNITY HOSPITAL ULTRASOUND INITIATIVE	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$138,626	approved, future	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT	202400379349100025
2023	Clalit Health Services Tel Aviv	U	$137,856	paid	ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT	202400379349100025
2023	Medical University of South Carolina Charleston, SC	C	$137,500	approved, future	ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$137,417	approved, future	INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$137,153	approved, future	INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD	202400379349100025
2023	River's Edge Hospital and Clinic St Peter, MN	U	$135,695	paid	TELE-EMERGENCY SERVICES FOR RIVER'S EDGE HOSPITAL	202400379349100025
2023	University of Dundee Dundee	U	$133,804	approved, future	HYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA	202400379349100025
2023	Jdrf International New York, NY	U	$133,334	paid	CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE	202400379349100025
2023	Jdrf International New York, NY	U	$133,334	approved, future	CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE	202400379349100025
2023	Jdrf International New York, NY	U	$133,332	approved, future	CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE	202400379349100025
2023	Stiftelsen for Utbildning (ioibd) Orebro	U	$132,000	paid	THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD	202400379349100025
2023	Stiftelsen for Utbildning (ioibd) Orebro	U	$132,000	approved, future	THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD	202400379349100025
2023	Stiftelsen for Utbildning (ioibd) Orebro	U	$132,000	approved, future	THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD	202400379349100025
2023	Nevada Department of Health and Human Services Carson City, NV	U	$130,670	approved, future	NEVADA FIRST RESPONDER AED PROJECT	202400379349100025
2023	Stevens Community Medical Center Inc Morris, MN	B	$130,205	paid	ULTRASOUND REVITALIZATION PROJECT	202400379349100025
2023	The Governors of the University of Calgary Calgary	D	$127,077	approved, future	INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD	202400379349100025
2023	University of Zurich Ch	U	$126,830	paid	GENERATE BISPECIFIC INTERLEUKIN-2 IMMUNOTHERAPY TO TREAT T1D MELLITUS	202400379349100025

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.